System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm

ABSTRACT

Embodiments of the invention provide a system for temperature control of the human body. The system includes an indwelling catheter with a tip-mounted heat transfer element. The catheter is fluidically coupled to a console that provides a heated or cooled heat transfer working fluid to exchange heat with the heat transfer element, thereby heating or cooling blood. The heated or cooled blood then heats or cools the patient&#39;s body or a selected portion thereof. In particular, methods and devices, including software, are provided for administering cooling or rewarming and controlling the same based on a projected control temperature measured by a temperature sensor within the catheter.

CONTINUING INFORMATION

This application claims the benefit of priority of U.S. ProvisionalApplication No. 60/449,803, flied Feb. 24, 2003 and 60/449,809, filedFeb. 24, 2003 and 60/456,137 filed Mar. 20, 2003 and 60/504,145 filedSep. 17, 2003.

This application is a continuation-in-part of:

1- U.S. application Ser. No. 10/158,406, filed May 29, 2002, U.S. Pat.No. 6,755,850 which is a continuation of U.S. application Ser. No.09/650,940, filed Aug. 30, 2000, U.S.Pat. No. 6,482,226, which is acontinuation of U.S. application Ser. No. 09/306,866, filed May 7, 1999,U.S. Pat. No. 6,235,048, which is a divisional application of U.S.application Ser. No. 09/012,287, filed Jan. 23, 1998, U.S. Pat. No.6,051,019;

2- this application is also a continuation-in-part of U.S. applicationSer. No. 09/785,243, filed Feb. 16, 2001, U.S. Pat. No. 6,818,011, whichis a continuation of U.S. application Ser. No. 09/052,545, filed Mar.31, 1998, U.S. Pat. No. 6,231,595;

3- this application is also a continuation-in-part of U.S. applicationSer. No. 09/834,068, filed Apr. 12, 2001, U.S. Pat. No. 6,692,488, whichis a continuation of U.S. application Ser. No. 09/566,531, filed May 8,2000, now abandoned, which is a continuation of U.S. application Ser.No. 09/103,342, filed Jun. 23, 1998, U.S. Pat. No. 6,096,068, which is acontinuation-in-part of U.S. application Ser. No. 09/047,012, filed onMar. 24, 1998, U.S. Pat. No. 5,957,963, which is a continuation-in-partof U.S. Application Ser. No. 09/012,287, filed Jan. 23, 1998, U.S. Pat.No. 6,051,019 and a continuation of U.S. application Ser. No.09/785,243, filed Feb. 16, 2001, U.S. Pat. No. 6,818,011 which is acontinuation of U.S. application Ser. No. 09/052,545, Mar. 31, 1998,U.S. Pat. No. 6,231,595;

4- this application is also a continuation-in-part of U.S. applicationSer. No. 10/714,070, filed Nov. 14, 2003, now abandoned which is acontinuation of U.S. application Ser. No. 10/095,753, filed on Mar. 11,2002, U.S. Pat. No. 6,695,873, which is a divisional application of U.S.application Ser. No. 09/757,124, filed on Jan. 8, 2001, U.S. Pat. No.6,540,771, which is a divisional of U.S. application 09/215,038 filed onDec. 16, 1998, U.S. Pat. No. 6,261,312, which is a continuation-in-partof U.S. application Ser No. 09/103,342 filed on Jun. 23, 1998, U.S. Pat.No. 6,096,068, which is a continuation-in-part of U.S. Application Ser.No. 09/047,012 filed on Mar. 24, 1998, U.S. Pat. No. 5,957,963, which isa continuation-in-part of U.S. application Ser No. 09/012,287 filed onJan. 23, 1998, U.S. Pat. No. 6,051,019;

5- this application is also a continuation-in-part of U.S. applicationSer. No. 10/322,337, filed Dec. 16, 2002, U.S. Pat. No. 6,740,109, whichis a continuation of co-pending U.S. application Ser. No. 09/292,532,filed Apr. 15, 1999, now abandoned, which is a continuation-in-part ofU.S. application Ser. No. 09/103,342, filed on Jun. 23, 1998, U.S. Pat.No. 6,096,068 and a continuation-in-part of U.S. application Ser. No.09/052,545, filed Mar. 31, 1998, U.S. Pat. No. 6,231,595 and acontinuation-in-part of U.S. application Ser. No. 09/047,012, filed onMar. 24, 1998, U.S. Pat. No. 5,957,963;

6- this application is also a continuation-in-part of U.S. applicationSer. No. 09/379,295, filed Aug. 23, 1999, now abandoned;

7- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 10/716,801, filed Nov 18, 2003, now U.S. Pat. No.7,052,508 which is a continuation of U.S. application Ser. No.09/414,184, filed Oct. 7, 1999, U.S. Pat. No. 6,325,818;

8- this application is also a continuation-in-part of U.S. applicationSer. No. 10/210,819, filed Jul. 31, 2002, U.S. Pat. No. 6,679,907, whichis a continuation of U.S. application Ser. No. 09/246,788 filed Feb. 9,1999, U.S. Pat. No. 6,491,716, which is a continuation-in-part of U.S.application Ser. No. 09/103,342, filed Jun. 23, 1998, U.S, Pat. No.6,096,088 and a continuation-in-part of U.S. application Ser. No.09/052,545, filed Mar. 31, 1998, U.S. Pat. No. 6,231,595 and acontinuation-in-part of U.S. application Ser. No. 09/047,012, filed Mar.24, 1998, U.S. Pat. No. 5,957,963 and a continuation-in-part of U.S.application Ser. No. 09/215,038, filed Dec. 16, 1998, U.S. Pat. No.6,261,312 and a continuation-in-part of U.S. application Ser. No.09/215,039, filed on Dec. 16, 1998, U.S. Pat. No. 6,251,129 and acontinuation-in-part of U.S. application Ser. No. 09/232,177, filed onJan. 15, 1999, U.S. Pat. No. 6,245,095;

9- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 09/908,642, filed Jul. 18, 2001;

10- this application is also a continuation-in-part of U.S. applicationSer. No. 10/161,107, filed May 30, 2002, U.S. Pat. No. 6,702,842, whichis a continuation of U.S. application Ser. No. 09/607,799, filed Jun.30, 2000, U.S. Pat. No. 6,464,716, which is a continuation-in-part ofU.S. application Ser. No. 09/570,075, filed May 12, 2000, U.S. Pat. No.6,471,717 and a continuation-in-part of U.S. application Ser. No.09/215,041, filed Dec. 16, 1998, U.S. Pat. No. 6,254,626 and acontinuation-in-part of U.S. application Ser. No. 09/103,342, filed Jun.23, 1998, U.S. Pat. No. 6,096,068 and a continuation-in-part of U.S.application Ser. No. 09/052,545, filed Mar. 31, 1998, U.S. Pat. No.6,231,595 and a continuation-in-part of U.S. patent application Ser. No.09/047,012, filed Mar. 24, 1998, U.S. Pat. No. 5,957,963 and acontinuation-in-part of U.S. application Ser. No. 09/012,287, filed Jan.23, 1998, U.S. Pat. No. 6,051,019;

11- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 10/729,526, filed Dec. 5, 2003, now U.S. Pat. No.7,211,105 which is continuation of U.S. application Ser. No. 10/082,964,filed Feb. 25, 2002, U.S. Pat. No. 6,660,028 which is a continuation ofU.S. application Ser. No. 09/586,000, filed Jun. 2, 2000, U.S. Pat. No.6,383,210;

12- this application is also a continuation-in-part of U.S. applicationSer. No. 10/008,999, filed Dec. 7, 2001, U.S. Pat. No. 6,786,218, whichis a continuation-in-part of co-pending U.S. application Ser. No.09/373,112 filed Aug. 11, 1999 and a continuation-in-part of U.S.application Ser. No. 09/103,342 filed Jun. 23, 1998, U.S. Pat. No.6,096,068, which is a continuation-in-part of U.S. application Ser. No.09/047,012 filed Mar. 24, 1998, U.S. Pat. No. 5,957.963;

13- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 09/373,112, filed Aug. 11, 1999, which is aContinuation-in-part of 09/292,532, filed Apr. 15, 1999 now abandoned,and a Continuation-in-part of U.S. application Ser. No. 09/103,342 filedJun. 23, 1998, U.S. Pat. No. 6,096,068 and a Continuation-in-part ofU.S. application Ser. No 09/052,545 filed Mar. 31, 1998, U.S. Pat. No.6,231,595 and a Continuation-in-part of U.S. application Ser. No.09/047,012 filed Mar 24, 1998, U.S. Pat. No. 5,957,963 and aContinuation-in-part of U.S. application Ser. No. 09/012,287 filed Jan.23, 1998, U.S. Pat. No. 6,051,019;

14- this application is also a continuation-in-part of U.S. applicationSer. No. 10/007,545, filed Nov. 6, 2001, U.S. Pat. No. 6,719,779, whichclaims the benefit of priority to U.S. Provisional application No.60/247,203, filed Nov. 7, 2000;

15- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 10/411,001, filed Apr. 9, 2003, now U.S. Pat. No.7,094,253 which is a continuation of U.S. application Ser. No.10/005,416 filed Nov. 7, 2001, U.S. Pat. No. 6,585,752, which claims thebenefit of priority to U.S. Provisional Application No. 60/246,620,filed Nov. 7, 2000 and is a continuation-in-part U.S. application Ser.No. 09/586,000, filed Jun. 2, 2000, U.S. Pat. No. 6,383,210 and U.S.application Ser. No. 09/566,531, filed May 8, 2000, now abandoned, whichis a continuation of U.S. application Ser. No. 09/103,342, filed Jun.23, 1998, U.S. Pat. No. 6,096,068, which is a continuation-in-part ofU.S. application Ser. No. 09/047,012, filed Mar. 24, 1998, U.S. Pat. No.5,957,963, which is a continuation-in-part of U.S. application Ser. No.09/012,287, filed Jan. 23, 1998, U.S. Pat. No. 6,051,019;

16- this application is also a continuation-in-part of U.S. applicationSer. No. 10/117,733, filed Apr. 4, 2002, U.S. Pat. No. 6,702,841, whichclaims priority to U.S. Provisional Patent Application No. 60/281,771,filed Apr. 5, 2001, and is a continuation-in-part of U.S. applicationSer. No. 09/607,799, filed Jun. 30, 2000, U.S. Pat. No. 6,464,716, whichis a continuation-in-part of U.S. application Ser. No. 09/215,041, filedDec. 16, 1998, U.S. Pat. No. 6,254,626 and a continuation-in-part ofU.S. application Ser. No. 09/379,295, filed Aug. 23, 1999, nowabandoned, which is a continuation-in-part of U.S. application Ser. No.09/103,342, filed Jun. 23, 1998, U.S. Pat. No. 6,096,068, which is acontinuation-in-part of U.S. application Ser. No. 09/047,012, filed Mar.24, 1998, U.S. Pat. No. 5,957,963, which is a continuation-in-part ofU.S. application Ser. No. 09/012,287, filed Jan. 23, 1998, U.S. Pat. No.6,051,019;

17- this application is also a continuation-in-part of co-pending U.S.application Ser. No. 10/219,874, filed Aug. 14, 2002, which claims thebenefit of priority of U.S. Provisional Application No. 60/311,589,filed Aug. 9, 2001 and the benefit of priority U.S. ProvisionalApplication No. 60/312,409, filed Aug. 15, 2001 and the benefit ofpriority U.S. Provisional Application No. 60/316,057, filed Aug. 29,2001 and the benefit of priority U.S. Provisional Application No.60/316,922, filed Aug. 31, 2001 and the benefit of priority U.S.Provisional Application No. 60/322,945; filed Sep. 14, 2001 and is acontinuation-in-part of U.S. application Ser. No. 09/650,940, filed Aug.30, 2000, U.S. Pat. No. 6,482,226 and a continuation-in-part of U.S.application Ser. No. 09/785,243, filed Feb. 16, 2001, U.S. Pat. No.6,818,011 and a continuation-in-part of U.S. application Ser. No.09/566,531, filed on May 8, 2000, now abandoned and acontinuation-in-part of U.S. application Ser. No. 09/757,124, filed Jan.8, 2001, U.S. Pat. No. 6,540,771 and a continuation-in-part of U.S.application Ser. No. 09/714,749, filed on Nov. 16, 2000, U.S. Pat. No.6,468,296 and a continuation-in-part of U.S. application Ser. No.09/621,051, filed on Jul. 21, 2000, U.S. Pat. No. 6,582,455 and acontinuation-in-part of U.S. application Ser. No. 09/800,159, filed onMar. 6, 2001, now abandoned, and a continuation-in-part of U.S.application Ser. No. 09/292,532 filed on Apr. 15, 1999, now abandoned,and a continuation-in-part of U.S. application Ser. No. 09/379,295,filed on Aug. 23, 1999, now abandoned, and a continuation-in-part ofU.S. application Ser. No. 09/885,655, filed on Jun. 20, 2001, U.S. Pat.No. 6,676,680 and a continuation-in-part of U.S. application Ser. No.09/246,788, filed Mar. 28, 2001, U.S. Pat. No. 6,491,716 and acontinuation-in-part of U.S. application Ser. No. 09/797,028, filed onFeb. 27, 2001, now abandoned, and a continuation-in-part of U.S.application Ser. No. 09/607,799, filed on Jun. 30, 2000, U.S. Pat. No.6,464,716 and a continuation-in-part of U.S. application Ser. No.09/519,022, filed on Mar. 3, 2000, U.S. Pat. No. 6,379,378 and acontinuation-in-part of U.S. application Ser. No. 10/082,964, filed onFeb. 25, 2002, U.S. Pat. No. 6,660,028 and a continuation-in-part ofU.S. application Ser. No. 09/539,932, filed on Mar. 31, 2000, U.S. Pat.No. 6,491,039 and a continuation-in-part of U.S. application Ser. No.09/658,950, filed on Sep. 11, 2000, now abandoned, and acontinuation-in-part of co-pending U.S. application Ser. No 09/373,112,filed on Aug. 11, 1999 and a continuation-in-part of U.S. applicationSer. No. 10/007,545, filed on Nov. 6, 2001, U.S. Pat. No. 6,719,779 anda continuation-in-part of U.S. application Ser. No. 10/005,416, filed onNov. 7, 2001, U.S. Pat. No. 6,585.752 and a continuation-in-part of U.S.application Ser. No. 10/117,733, filed Apr. 4, 2002, U.S. Pat. No.6,702,841; all of the above are incorporated by reference herein intheir entirety.

FIELD OF THE INVENTION

The present invention relates generally to the lowering, raising, andcontrol of the temperature of the human body. More particularly, theinvention relates to a method and intravascular apparatus forcontrolling the temperature of the human body.

BACKGROUND

Background Information—Organs in the human body, such as the brain,kidney and heart, are maintained at a constant temperature ofapproximately 37° C. Hypothermia can be clinically defined as a corebody temperature of 35° C. or less. Hypothermia is sometimescharacterized further according to its severity. A body core temperaturein the range of 33° C. to 35° C. is described as mild hypothermia. Abody temperature of 28° C. to 32° C. is described as moderatehypothermia. A body core temperature in the range of 24° C. to 28° C. isdescribed as severe hypothermia.

Hypothermia is uniquely effective in reducing ischemia. For example, itis effective in reducing brain injury caused by a variety ofneurological insults and may eventually play an important role inemergency brain resuscitation. Experimental evidence has demonstratedthat cerebral cooling improves outcome after global ischemia, focalischemia, or traumatic brain injury. For this reason, hypothermia may beinduced in order to reduce the effect of certain bodily injuries to thebrain as well as ischemic injuries to other organs.

BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of this invention, as well as the invention itself,will be best understood from the attached drawings, taken along with thefollowing description, in which similar reference characters refer tosimilar parts, and in which:

FIG. 1 is a schematic representation of the heat transfer element beingused in an embodiment within the superior vena cava;

FIG. 2 is an elevational view of a mixing inducing heat transfer elementwithin a blood vessel;

FIG. 3 is a schematic diagram of a heat transfer element according to anembodiment of the invention;

FIG. 4 is a graph showing the relationship between the Nusselt number(Nu) and the Reynolds number (Re) for air flowing through a long heatedpipe at uniform wall temperature;

FIG. 5 is an elevation view of one embodiment of a heat transfer elementaccording to the invention;

FIG. 6 is a longitudinal section view of the heat transfer element ofFIG. 5;

FIG. 7 is a transverse section view of the heat transfer element of FIG.5;

FIG. 8 is a perspective view of the heat transfer element of FIG. 5 inuse within a blood vessel;

FIG. 9 is a perspective view of another embodiment of a heat transferelement according to the invention, with aligned longitudinal ridges onadjacent segments;

FIG. 10 is a transverse section view of the heat transfer element ofFIG. 9;

FIG. 11 is a cut-away perspective view of an alternative embodiment of aheat transfer element according to the invention;

FIG. 12 is a transverse section view of the heat transfer element ofFIG. 11;

FIG. 13 is a front sectional view of a further embodiment of a catheteremploying a heat transfer element according to the principles of theinvention further employing a side-by-side lumen arrangement constructedin accordance with an embodiment of the invention;

FIG. 14 is a cross-sectional view of the catheter of FIG. 13 taken alongline 14-14 of FIG. 13;

FIG. 15 is a front sectional view of a catheter employing a heattransfer element and lumen arrangement constructed in accordance with afurther embodiment of the invention;

FIG. 16 is a front sectional view of a catheter employing a heattransfer element and lumen arrangement constructed in accordance with astill further embodiment of the invention;

FIG. 17 is a front sectional view of another embodiment of a catheteremploying a heat transfer element according to the principles of theinvention further employing a side-by-side lumen arrangement constructedin accordance with another embodiment of the invention;

FIG. 18 is a cross-sectional view of the heat transfer elementillustrated in FIG. 17;

FIG. 19 is a side schematic view of an inflatable heat transfer elementaccording to an embodiment of the invention, as the same is disposedwithin a blood vessel;

FIG. 20 illustrates an inflatable turbulence-inducing heat transferelement according to an alternative embodiment of the inventionemploying a surface area enhancing taper and a turbulence-inducingshape;

FIG. 21 illustrates a tapered joint which may be employed in theembodiment of FIG. 16;

FIG. 22 illustrates a turbulence-inducing heat transfer elementaccording to a second alternative embodiment of the invention employinga surface area enhancing taper and turbulence-inducing surface features;

FIG. 23 illustrates a spiral type of turbulence-inducing surface featurewhich may be employed in the heat transfer element of the embodiment ofFIG. 22;

FIG. 24 illustrates a heat transfer element according to an alternativeembodiment of the invention employing a surface area enhancing taper;

FIG. 25 is a perspective view of a further embodiment of the device ofthe present invention in place in a blood vessel of a patient;

FIG. 26 is another perspective view of the device shown in FIG. 25, withadditional details of construction;

FIG. 27 is a transverse section view of the device shown in FIG. 26,along the section line 27-27;

FIG. 28 is a partial longitudinal section view of the device shown inFIG. 25, showing the flow path of the cooling fluid;

FIG. 29 is a perspective view of a console system including acirculation set constructed in accordance with an embodiment of theinvention;

FIG. 30 is a schematic diagram of a circulation set according to anembodiment of the invention;

FIG. 31 shows a system that may be used to implement a predictivetemperature algorithm;

FIG. 32 shows a junction between a heat transfer element and a cathetershowing position of a catheter-mounted heat transfer element;

FIG. 33 shows a heat transfer element and catheter showing position of adistal tip catheter-mounted temperature sensor.

FIG. 34 shows a pump duty cycle;

FIG. 35 shows two pump duty cycles and the achievement of a higher dutycycle, compared to that of FIG. 34, when a predictive temperaturealgorithm is employed;

FIG. 36 shows one graphical method of predicting a control temperature;

FIG. 37 shows the relationship of the ratio of areas, before measurementand after measurement, with respect to time;

FIG. 38 shows another method of predicting a control temperature;

FIG. 39 shows a system that may implement a method of predicting controltemperatures;

FIG. 40 shows a graph of the areas of, e.g., FIG. 37;

FIG. 41 shows another system for implementing a method of predictingcontrol temperatures;

FIG. 42 shows a comparator switch which may be used in the embodimentof, e.g., FIG. 41;

FIG. 43 is a flowchart showing an exemplary method of the inventionemploying heating blankets and thermoregulatory drugs;

DETAILED DESCRIPTION

Overview

In the following description, the term “pressure communication” is usedto describe a situation between two points in a flow or in a standing orflowing fluid. If pressure is applied at one point, the second pointwill eventually feel effects of the pressure if the two points are inpressure communication. Any number of valves or elements may be disposedbetween the two points, and the two points may still be in pressurecommunication if the above test is met. For example, for a standingfluid in a pipe, any number of pipe fittings may be disposed between twopipes and, so long as an open path is maintained, points in therespective pipes may still be in pressure communication.

A device may be employed to intravascularly lower the temperature of abody in order to cause therapeutic hypothermia. A cooling element may beplaced in a high-flow vein such as the vena cavae to absorb heat fromthe blood flowing into the heart. This transfer of heat causes a coolingof the blood flowing through the heart and thus throughout thevasculature. Such a method and device may therapeutically be used toinduce, and reverse, an artificial state of hypothermia.

A heat transfer element that systemically cools blood should be capableof providing the necessary heat transfer rate to produce the desiredcooling effect throughout the vasculature. This may be up to or greaterthan 300 watts, and is at least partially dependent on the mass of thepatient and the rate of blood flow. Surface features may be employed onthe heat transfer element or as part of the heat transfer element toenhance the heat transfer rate. The surface features and othercomponents of the heat transfer element are described in more detailbelow.

One problem with hypothermia as a therapy is that the patient'sthermoregulatory defenses initiate, attempting to defeat thehypothermia. Methods and devices may be used to lessen thethermoregulatory response. For example, a heating blanket may cover thepatient. In this way, the patient may be made more comfortable.Thermoregulatory drugs may also be employed to lower the trigger pointat which the patient's thermoregulatory system begins to initiatedefenses. Such drugs are described in more detail below. A methodemploying thermoregulatory drugs, heating blankets, and heat transferelements is also disclosed below.

Anatomical Placement

The internal jugular vein is the vein that directly drains the brain.The external jugular joins the internal jugular at the base of the neck.The internal jugular veins join the subclavian veins to form thebrachiocephalic veins that in turn drain into the superior vena cava.The superior vena cava drains into the right atrium of the heart as maybe seen by referring ahead to FIG. 1. The superior vena cava suppliesblood to the heart from the upper part of the body.

A cooling element 102 may be placed into the superior vena cava 110,inferior vena cava 110′, or otherwise into a vein which feeds into thesuperior vena cava, inferior vena cava, or otherwise into the heart tocool the body. A physician percutaneously places the catheter into thesubclavian or internal or external jugular veins to access the superiorvena cava. A physician percutaneously places the catheter into thefemoral vein to access the inferior vena cava. The blood, cooled by theheat transfer element, may be processed by the heart and provided to thebody in oxygenated form to be used as a conductive medium to cool thebody. The lungs have a fairly low heat capacity, and thus the lungs donot cause appreciable rewarming of the flowing blood.

Heat Transfer

When a heat transfer element is inserted into an artery or vein, theprimary mechanism of heat transfer between the surface of the heattransfer element and the blood is forced convection. Convection reliesupon the movement of fluid to transfer heat. Forced convection resultswhen an external force causes motion within the fluid. In the case ofarterial or venous flow, the beating heart causes the motion of theblood around the heat transfer element. The magnitude of the heattransfer rate is proportional to the surface area of the heat transferelement, the temperature differential, and the heat transfer coefficientof the heat transfer element.

The receiving artery or vein into which the heat transfer element isplaced has a limited diameter and length. Thus, the surface area of theheat transfer element must be limited to avoid significant obstructionof the artery or vein and to allow the heat transfer element to easilypass through the vascular system. For placement within the superior venacava via the external jugular, the cross sectional diameter of the heattransfer element may be limited to about 5-6 mm, and its length may belimited to approximately 10-15 cm. For placement within the inferiorvena cava, the cross sectional diameter of the heat transfer element maybe limited to about 6-7 mm, and its length may be limited toapproximately 25-35 cm.

Decreasing the surface temperature of the heat transfer element canincrease the temperature differential. However, the minimum allowablesurface temperature is limited by the characteristics of blood. Bloodfreezes at approximately 0° C. When the blood approaches freezing, iceemboli may form in the blood, which may lodge downstream, causingserious ischemic injury. Furthermore, reducing the temperature of theblood also increases its viscosity, which results in a small decrease inthe value of the convection heat transfer coefficient. In addition,increased viscosity of the blood may result in an increase in thepressure drop within the vessel, thus compromising the flow of blood tothe brain. Given the above constraints, it may be advantageous to limitthe minimum allowable surface temperature of the cooling element toapproximately 5° C. This results in a maximum temperature differentialbetween the blood stream and the cooling element of approximately 32° C.For other physiological reasons, there are limits on the maximumallowable surface temperature of the warming element.

The mechanisms by which the value of the convection heat transfercoefficient may be increased are complex. However, it is well known thatthe convection heat transfer coefficient increases with the level of“mixing” or “turbulent” kinetic energy in the fluid flow. Thus it may beadvantageous to have blood flow with a high degree of mixing in contactwith the heat transfer element.

The blood flow has a considerably more stable flux in the superior orinferior vena cava than in an artery. However, the blood flow in thesuperior vena cava still has a high degree of inherent mixing orturbulence. Reynolds numbers in the superior vena cava may range, forexample, from 2,000 to 5,000. Thus, blood cooling in the vena cava maybenefit from enhancing the level of mixing with the heat transferelement but this benefit may be substantially less than that caused bythe inherent mixing.

A thin boundary layer has been shown to form during the cardiac cycle.Boundary layers develop adjacent to the heat transfer element as well asnext to the walls of the artery or vein. Each of these boundary layershas approximately the same thickness as the boundary layer that wouldhave developed at the wall of the artery in the absence of the heattransfer element. The free stream flow region is developed in an annularring around the heat transfer element. The heat transfer element used insuch a vessel should reduce the formation of such viscous boundarylayers.

Heat Transfer Element Characteristics

The intravascular heat transfer element should be flexible in order tobe placed within the vena cavae or other veins or arteries. Theflexibility of the heat transfer element is an important characteristicbecause the same is typically inserted into a vein such as the externaljugular and accesses the superior vena cava by initially passing thougha series of one or more branches. Further, the heat transfer element isideally constructed from a highly thermally conductive material such asmetal or a thin polymer or a doped polymer in order to facilitate heattransfer. The use of a highly thermally conductive material increasesthe heat transfer rate for a given temperature differential between theworking fluid within the heat transfer element and the blood. Thisfacilitates the use of a higher temperature coolant, or lowertemperature warming fluid, within the heat transfer element, allowingsafer working fluids, such as water or saline, to be used. Highlythermally conductive materials, such as metals, tend to be rigid.Therefore, the design of the heat transfer element should facilitateflexibility in an inherently inflexible material.

It is estimated that the cooling element should absorb at least about300 Watts of heat when placed in the superior vena cava to lower thetemperature of the body to between about 30° C. and 34° C. Thesetemperatures are thought to be appropriate to obtain the benefits ofhypothermia described above. The power removed determines how quicklythe target temperature can be reached. For example, in a stroke therapyin which it is desired to lower brain temperature, the same may belowered about 4° C. per hour in a 70 kg human upon removal of 300 Watts.

One embodiment of the invention uses a modular design. This designcreates helical blood flow and produces a level of mixing in the bloodflow by periodically forcing abrupt changes in the direction of thehelical blood flow. The abrupt changes in flow direction are achievedthrough the use of a series of two or more heat transfer segments, eachincluding one or more helical ridges. The use of periodic abrupt changesin the helical direction of the blood flow in order to induce strongfree stream turbulence may be illustrated with reference to a commonclothes washing machine. The rotor of a washing machine spins initiallyin one direction causing laminar flow. When the rotor abruptly reversesdirection, significant turbulent kinetic energy is created within theentire washbasin as the changing currents cause random turbulent motionwithin the clothes-water slurry. These surface features also tend toincrease the surface area of the heat transfer element, furtherenhancing heat transfer.

A heat transfer element with a smooth exterior surface may be able toprovide the desired amount of heat transfer. However, as noted above, itis well known that the convection heat transfer coefficient increaseswith the level of turbulent kinetic energy in the fluid flow. Thus, ifflow past a smooth heat transfer element will not transfer sufficientheat, it is advantageous to have turbulent or otherwise mixed blood flowin contact with the heat transfer element.

As noted above, the helical designs create helical blood flow andproduce a high level of mixing in the free stream. For a swirling flowin a tube in which the azimuthal velocity of the fluid vanishes towardthe stationary outer boundary, any non-vanishing azimuthal velocity inthe interior of the flow will result in an instability in which theinner fluid is spontaneously exchanged with fluid near the wall,analogous to Taylor cells in the purely azimuthal flow between arotating inner cylinder and stationary outer cylinder. This instabilityresults from the lack of any force in opposition to the centripetalacceleration of the fluid particles moving along helical paths, thepressure in the tube being a function only of longitudinal position.

In one embodiment, the device of the present invention imparts anazimuthal velocity to the interior of a developed pipe flow, with thenet result being a continuous exchange of fluid between the core andperimeter of the flow as it moves longitudinally down the pipe. Thisfluid exchange enhances the transport of heat, effectively increasingthe convective heat transfer coefficient over that which would haveobtained in undisturbed pipe flow. This bulk exchange of fluid is notnecessarily turbulent, although turbulence is possible if the inducedazimuthal velocity is sufficiently high.

FIG. 2 is a perspective view of a mixing-inducing heat transfer elementwithin an artery or vein. In this embodiment, turbulence or mixing isfurther enhanced by periodically forcing abrupt changes in the directionof the helical blood flow. Turbulent or mixed flow would be found atpoint 120, in the free stream area. The abrupt changes in flow directionare achieved through the use of a series of two or more heat transfersegments, each comprised of one or more helical ridges. Ideally, thesegments will be close enough together to prevent re-laminarization ofthe flow in between segments.

A device according to an embodiment of the invention for accomplishingsuch cooling or heating is shown schematically in FIG. 3, which shows avessel wall 132 in which a blood flow 122 is passing. A catheter 130 isdisposed within the blood flow 122 to affect the blood temperature.Catheter 130 has an inlet lumen 126 for providing a working fluid 128and an outlet lumen 124 for draining the working fluid 128. Thefunctions of the respective lumens may of course be opposite to thatstated.

Heat transfer in this system is governed by the following mechanisms:

(1) convective heat transfer from the blood 122 to the outlet lumen 124;

(2) conduction through the wall of the outlet lumen 124;

(3) convective heat transfer from the outlet lumen 124 to the workingfluid 128;

(4) conduction through the working fluid 128;

(5) convective heat transfer from working fluid 128 in the outlet lumen124 to the inlet lumen 126; and

(6) conduction through the wall of the inlet lumen 126.

Once the materials for the lumens and the working fluid are chosen, theconductive heat transfers are solely dependent on the temperaturegradients. Convective heat transfers, by contrast, also rely on themovement of fluid to transfer heat. Forced convection results when theheat transfer surface is in contact with a fluid whose motion is induced(or forced) by a pressure gradient, area variation, or other such force.In the case of blood flow, the beating heart provides an oscillatorypressure gradient to force the motion of the blood in contact with theheat transfer surface. One of the aspects of the device uses mixing orturbulence to enhance this forced convective heat transfer.

The rate of convective heat transfer Q is proportional to the product ofS, the area of the heat transfer element in direct contact with thefluid, ΔT=T_(b)−T_(s), the temperature differential between the surfacetemperature T_(s) of the heat transfer element and the free stream bloodtemperature T_(b), and h_(c) , the average convection heat transfercoefficient over the heat transfer area. h_(c) is sometimes called the“surface coefficient of heat transfer” or the “convection heat transfercoefficient”.

The magnitude of the heat transfer rate Q to or from the fluid flow canbe increased through manipulation of the above three parameters.Practical constraints limit the value of these parameters and how muchthey can be manipulated. For example, the internal diameter of thecommon carotid artery ranges from 6 to 8 mm. Thus, the heat transferelement residing therein may not be much larger than 4 mm in diameter toavoid occluding the vessel. The length of the heat transfer elementshould also be limited. For placement within the internal and commoncarotid artery, the length of the heat transfer element is limited toabout 10 cm. This estimate is based on the length of the common carotidartery, which ranges from 8 to 12 cm. Embodiments intended for use inthe venous system would be analyzed similarly. For these venous systems,catheter sizes may be, e.g., 9 French, 10.7 French, 14 French, etc.

Consequently, the value of the surface area S is limited by the physicalconstraints imposed by the size of the vessel into which the device isplaced. Surface features, such as fins, can be used to increase thesurface area of the heat transfer element, however, these features alonegenerally cannot usually provide enough surface area enhancement to meetthe required heat transfer rate.

An embodiment of the device described below provides a tapered heattransfer element which employs a large surface area but which mayadvantageously fit into small arteries and veins. As the device isinflatable, the same may be inserted in relatively small arteries andveins in a deflated state, allowing a minimally invasive entry. When thedevice is in position, the same may be inflated, allowing a largesurface area and thus an enhanced heat transfer rate.

One may also attempt to vary the magnitude of the heat transfer rate byvarying ΔT. The value of ΔT=T_(b)−T_(s) can be varied by varying thesurface temperature T_(s) of the heat transfer element. The allowablesurface temperature of the heat transfer element is limited by thecharacteristics of blood. The blood temperature is fixed at about 37°C., and blood freezes at approximately 0° C. When the blood approachesfreezing, ice emboli may form in the blood which may lodge downstream,causing serious ischemic injury. Furthermore, reducing the temperatureof the blood also increases its viscosity which results in a smalldecrease in the value of h_(c) . Increased viscosity of the blood mayfurther result in an increase in the pressure drop within the vessel,thus compromising the flow of blood. Given the above constraints, it maybe advantageous to limit the surface temperature of the heat transferelement to approximately 1° C.-5° C., thus resulting in a maximumtemperature differential between the blood stream and the heat transferelement of approximately 32° C.-36° C.

One may also attempt to vary the magnitude of the heat transfer rate byvarying h_(c) . Fewer constraints are imposed on the value of theconvection heat transfer coefficient h_(c) . The mechanisms by which thevalue of h_(c) may be increased are complex. However, one way toincrease h_(c) for a fixed mean value of the velocity is to increase thelevel of turbulent kinetic energy in the fluid flow.

The heat transfer rate Q_(no-flow) in the absence of fluid flow isproportional to ΔT, the temperature differential between the surfacetemperature T_(s) of the heat transfer element and the free stream bloodtemperature T_(b) times k, the diffusion constant, and is inverselyproportion to δ, the thickness of the boundary layer.

The magnitude of the enhancement in heat transfer by fluid flow can beestimated by taking the ratio of the heat transfer rate with fluid flowto the heat transfer rate in the absence of fluid flowN=Q_(flow)/Q_(no-flow)= h_(c) /(k/δ). This ratio is called the Nusseltnumber (“Nu”). For convective heat transfer between blood and thesurface of the heat transfer element, Nusselt numbers of 30-80 have beenfound to be appropriate for selective cooling applications of variousorgans in the human body. Nusselt numbers are generally dependent onseveral other numbers: the Reynolds number, the Womersley number, andthe Prandtl number.

Stirring-type mechanisms, which abruptly change the direction ofvelocity vectors, may be utilized to induce turbulent kinetic energy andincrease the heat transfer rate. The level of turbulence so created ischaracterized by the turbulence intensity I. Turbulence intensity I isdefined as the root mean square of the fluctuating velocity divided bythe mean velocity. Such mechanisms can create high levels of turbulenceintensity in the free stream, thereby increasing the heat transfer rate.For arterial applications, this turbulence intensity should ideally besustained for a significant portion of the cardiac cycle, and shouldideally be created throughout the free stream and not just in theboundary layer.

One type of turbulence-inducing heat transfer element which may beadvantageously employed to provide heating or cooling is described inU.S. Pat. No. 6,096,068 to Dobak and Lasheras for a “Selective OrganCooling Catheter and Method of Using the Same,” incorporated byreference above. In that application, the heat transfer element is madeof a high thermal conductivity material, such as metal. The metal heattransfer element provides a high degree of heat transfer due to its highthermal conductivity. In that application, bellows provided a highdegree of articulation that compensated for the intrinsic stiffness ofthe metal. The device size was minimized, e.g., less than 4 mm, toprevent blockage of the blood flowing in the vessel.

FIG. 4 illustrates the dependency of the Nusselt number on the Reynoldsnumber for a fluid flowing through a long duct, i.e., air flowing thougha long heated pipe at a uniform wall temperature. Although FIG. 4illustrates this relationship for a different fluid through a differentstructure, the inventors of the present invention believe a similarrelationship exists for blood flow through a blood vessel. FIG. 4illustrates that flow is laminar when the Reynolds number is below somenumber, in this case about 2100. In the range of Reynolds numbersbetween another set of numbers, in this case 2100 and 10,000, atransition from laminar to turbulent flow takes place. The flow in thisregime is called transitional. The mixing caused by the heat transferelement of the present invention produces a flow that is at leasttransitional. At another Reynolds number, in the case above, about10,000, the flow becomes fully turbulent.

The type of flow that occurs is important because in laminar flowthrough a duct, there is no mixing of warmer and colder fluid particlesby eddy motion. Thus, the only heat transfer that takes place is throughconduction. Since most fluids have small thermal conductivities, theheat transfer coefficients in laminar flow are relatively small. Intransitional and turbulent flow, mixing occurs through eddies that carrywarmer fluid into cooler regions and vice versa. Since the mixingmotion, even if it is only on a small scale compared to fully turbulentflow, accelerates the transfer of heat considerably, a marked increasein the heat transfer coefficient occurs above a certain Reynolds number,which in the graph of FIG. 4 is about 2100. It can be seen from FIG. 4that it is at approximately this point where the Nusselt numberincreases more dramatically. A different set of numbers may be measuredfor blood flow through an artery or vein. However, the inventors believethat a Nusselt number at least in the transitional region may beimportant for enhanced heat transfer.

Device

FIG. 5 is an elevation view of one embodiment of a cooling element 102according to the present invention. The heat transfer element 102includes a series of elongated, articulated segments or modules134,104,106. Three such segments are shown in this embodiment, but twoor more such segments could be used without departing from the spirit ofthe invention. As seen in FIG. 5, a first elongated heat transfersegment 134 is located at the proximal end of the heat transfer element102. A mixing-inducing exterior surface of the segment 134 includes fourparallel helical ridges 138 with four parallel helical grooves 136therebetween. One, two, three, or more parallel helical ridges 138 couldalso be used without departing from the spirit of the present invention.In this embodiment, the helical ridges 138 and the helical grooves 136of the heat transfer segment 134 have a left hand twist, referred toherein as a counter-clockwise spiral or helical rotation, as theyproceed toward the distal end of the heat transfer segment 134.

The first heat transfer segment 134 is coupled to a second elongatedheat transfer segment 104 by a first bellows section 140, which providesflexibility and compressibility. The second heat transfer segment 104includes one or more helical ridges 144 with one or more helical grooves142 therebetween. The ridges 144 and grooves 142 have a right hand, orclockwise, twist as they proceed toward the distal end of the heattransfer segment 104. The second heat transfer segment 104 is coupled toa third elongated heat transfer segment 106 by a second bellows section108. The third heat transfer segment 106 includes one or more helicalridges 148 with one or more helical grooves 146 therebetween. Thehelical ridge 148 and the helical groove 146 have a left hand, orcounter-clockwise, twist as they proceed toward the distal end of theheat transfer segment 106. Thus, successive heat transfer segments 134,104, 106 of the heat transfer element 102 alternate between havingclockwise and counterclockwise helical twists. The actual left or righthand twist of any particular segment is immaterial, as long as adjacentsegments have opposite helical twist.

In addition, the rounded contours of the ridges 138, 144, 148 allow theheat transfer element 102 to maintain a relatively atraumatic profile,thereby minimizing the possibility of damage to the blood vessel wall. Aheat transfer element according to the present invention may includetwo, three, or more heat transfer segments.

The bellows sections 140, 108 are formed from seamless and nonporousmaterials, such as metal, and therefore are impermeable to gas, whichcan be particularly important, depending on the type of working fluidthat is cycled through the heat transfer element 102. The structure ofthe bellows sections 140, 108 allows them to bend, extend and compress,which increases the flexibility of the heat transfer element 102 so thatit is more readily able to navigate through blood vessels. The bellowssections 140, 108 also provide for axial compression of the heattransfer element 102, which can limit the trauma when the distal end ofthe heat transfer element 102 abuts a blood vessel wall. The bellowssections 140, 108 are also able to tolerate cryogenic temperatureswithout a loss of performance. In alternative embodiments, the bellowsmay be replaced by flexible polymer tubes, which are bonded betweenadjacent heat transfer segments.

The exterior surfaces of the heat transfer element 102 can be made frommetal, and may include very high thermal conductivity materials such asnickel, thereby facilitating heat transfer. Alternatively, other metalssuch as stainless steel, titanium, aluminum, silver, copper and thelike, can be used, with or without an appropriate coating or treatmentto enhance biocompatibility or inhibit clot formation. Suitablebiocompatible coatings include, e.g., gold, platinum or polymerparalyene. The heat transfer element 102 may be manufactured by platinga thin layer of metal on a mandrel that has the appropriate pattern. Inthis way, the heat transfer element 102 may be manufacturedinexpensively in large quantities, which is an important feature in adisposable medical device.

Because the heat transfer element 102 may dwell within the blood vesselfor extended periods of time, such as 24-48 hours or even longer, it maybe desirable to treat the surfaces of the heat transfer element 102 toavoid clot formation. In particular, one may wish to treat the bellowssections 140, 108 because stagnation of the blood flow may occur in theconvolutions, thus allowing clots to form and cling to the surface toform a thrombus. One means by which to prevent thrombus formation is tobind an antithrombogenic agent to the surface of the heat transferelement 102. For example, heparin is known to inhibit clot formation andis also known to be useful as a biocoating. Alternatively, the surfacesof the heat transfer element 102 may be bombarded with ions such asnitrogen. Bombardment with nitrogen can harden and smooth the surfaceand thus prevent adherence of clotting factors. Another coating thatprovides beneficial properties may be a lubricious coating. Lubriciouscoatings, on both the heat transfer element and its associated catheter,allow for easier placement in the, e.g., vena cava.

FIG. 6 is a longitudinal sectional view of the heat transfer element 102of an embodiment of the invention, taken along line 6-6 in FIG. 5. Someinterior contours are omitted for purposes of clarity. An inner tube 150creates an inner lumen 158 and an outer lumen 156 within the heattransfer element 102. Once the heat transfer element 102 is in place inthe blood vessel, a working fluid such as saline or other aqueoussolution may be circulated through the heat transfer element 102. Fluidflows from a source into the inner lumen 158. At the distal end of theheat transfer element 102, the working fluid exits the inner lumen 158and enters the outer lumen 156. As the working fluid flows through theouter lumen 156, heat is transferred between the working fluid and theexterior surface 152 of the heat transfer element 102. Because the heattransfer element 102 is constructed from a high conductivity material,the temperature of its exterior surface 152 may reach very close to thetemperature of the working fluid. The tube 150 may be formed as aninsulating divider to thermally separate the inner lumen 158 from theouter lumen 156. For example, insulation may be achieved by creatinglongitudinal air channels in the wall of the insulating tube 150.Alternatively, the tube 150 may be constructed of a non-thermallyconductive material like polytetrafluoroethylene or another polymer.

It is important to note that the same mechanisms that govern the heattransfer rate between the exterior surface 152 of the heat transferelement 102 and the blood also govern the heat transfer rate between theworking fluid and the interior surface 154 of the heat transfer element102. The heat transfer characteristics of the interior surface 154 areparticularly important when using water, saline or other fluid thatremains a liquid as the working fluid. Other coolants such as Freonundergo nucleate boiling and create mixing through a differentmechanism. Saline is a safe working fluid, because it is non-toxic, andleakage of saline does not result in a gas embolism, which could occurwith the use of boiling refrigerants. Since mixing in the working fluidis enhanced by the shape of the interior surface 154 of the heattransfer element 102, the working fluid can be delivered to the coolingelement 102 at a warmer temperature and still achieve the necessarycooling rate. Similarly, since mixing in the working fluid is enhancedby the shape of the interior surface of the heat transfer element, theworking fluid can be delivered to the warming element 102 at a coolertemperature and still achieve the necessary warming rate.

This has a number of beneficial implications in the need for insulationalong the catheter shaft length. Due to the decreased need forinsulation, the catheter shaft diameter can be made smaller. Theenhanced heat transfer characteristics of the interior surface of theheat transfer element 102 also allow the working fluid to be deliveredto the heat transfer element 102 at lower flow rates and lowerpressures. High pressures may make the heat transfer element stiff andcause it to push against the wall of the blood vessel, thereby shieldingpart of the exterior surface 152 of the heat transfer element 102 fromthe blood. Because of the increased heat transfer characteristicsachieved by the alternating helical ridges 138, 144, 148, the pressureof the working fluid may be as low as 5 atmospheres, 3 atmospheres, 2atmospheres or even less than 1 atmosphere.

FIG. 7 is a transverse sectional view of the heat transfer element 102of the invention, taken at a location denoted by the line 7-7 in FIG. 5.FIG. 7 illustrates a five-lobed embodiment, whereas FIG. 5 illustrates afour-lobed embodiment. As mentioned earlier, any number of lobes mightbe used. In FIG. 7, the construction of the heat transfer element 102 isclearly shown. The inner lumen 158 is defined by the insulating tube150. The outer lumen 156 is defined by the exterior surface of theinsulating tube 150 and the interior surface 154 of the heat transferelement 102. In addition, the helical ridges 144 and helical grooves 142may be seen in FIG. 7. Although FIG. 7 shows five ridges and fivegrooves, the number of ridges and grooves may vary. Thus, heat transferelements with 1, 2, 3, 4, 5, 6, 7, 8 or more ridges are specificallycontemplated.

FIG. 8 is a perspective view of a heat transfer element 102 in usewithin a blood vessel, showing only one helical lobe per segment forpurposes of clarity. Beginning from the proximal end of the heattransfer element (not shown in FIG. 8), as the blood moves forward, thefirst helical heat transfer segment 104 induces a counter-clockwiserotational inertia to the blood. As the blood reaches the second segment104, the rotational direction of the inertia is reversed, causing mixingwithin the blood. Further, as the blood reaches the third segment 106,the rotational direction of the fluid is again reversed. The suddenchanges in flow direction actively reorient and randomize the velocityvectors, thus ensuring mixing throughout the bloodstream. During suchmixing, the velocity vectors of the blood become more random and, insome cases, become perpendicular to the axis of the vessel. Thus, alarge portion of the volume of warm blood in the vessel is activelybrought in contact with the heat transfer element 102 where it can becooled by direct contact rather than being cooled largely by conductionthrough adjacent laminar layers of blood.

Referring back to FIG. 5, the heat transfer element 102 has beendesigned to address all of the design criteria discussed above. The heattransfer element 102 is flexible and is made of a highly conductivematerial. The flexibility is provided by a segmental distribution ofbellows sections 140, 108 that provide an articulating mechanism.Bellows have a known convoluted design that provide flexibility. Theridges allow the heat transfer element 102 to maintain a relativelyatraumatic profile, thereby minimizing the possibility of damage to thevessel wall. The heat transfer element 102 has been designed to promotemixing both internally and externally. The modular or segmental designallows the direction of the grooves to be reversed between segments. Thealternating helical rotations create an alternating flow that results inmixing the blood in a manner analogous to the mixing action created bythe rotor of a washing machine that switches directions back and forth.This action is intended to promote mixing to enhance the heat transferrate. The alternating helical design also causes beneficial mixing, orturbulent kinetic energy, of the working fluid flowing internally.

FIG. 9 is a perspective view of a third embodiment of a heat transferelement 160 according to the present invention. The heat transferelement 160 is comprised of a series of elongated, articulated segmentsor modules 162. A first elongated heat transfer segment 162 is locatedat the proximal end of the heat transfer element 160. The segment 162may be a smooth right circular cylinder (not shown), or it canincorporate a turbulence-inducing or mixing-inducing exterior surface.The turbulence-inducing or mixing-inducing exterior surface shown on thesegment 162 in FIG. 16 comprises a plurality of parallel longitudinalridges 164 with parallel longitudinal grooves 168 therebetween. One,two, three, or more parallel longitudinal ridges 164 could be usedwithout departing from the spirit of the present invention. In theembodiment where they are used, the longitudinal ridges 164 and thelongitudinal grooves 168 of the heat transfer segment 162 are alignedparallel with the axis of the first heat transfer segment 162.

The first heat transfer segment 162 is coupled to a second elongatedheat transfer segment 162 by a first flexible section such as a bellowssection 166, which provides flexibility and compressibility.Alternatively, the flexible section may be a simple flexible tube, verysimilar to a smooth heat transfer segment, but flexible. The second heattransfer segment 162 also comprises a plurality of parallel longitudinalridges 164 with parallel longitudinal grooves 168 therebetween. Thelongitudinal ridges 164 and the longitudinal grooves 168 of the secondheat transfer segment 162 are aligned parallel with the axis of thesecond heat transfer segment 162. The second heat transfer segment 162is coupled to a third elongated heat transfer segment 162 by a secondflexible section such as a bellows section 166 or a flexible tube. Thethird heat transfer segment 162 also comprises a plurality of parallellongitudinal ridges 164 with parallel longitudinal grooves 168therebetween. The longitudinal ridges 164 and the longitudinal grooves168 of the third heat transfer segment 162 are aligned parallel with theaxis of the third heat transfer segment 162. Further, in thisembodiment, adjacent heat transfer segments 162 of the heat transferelement 160 have their longitudinal ridges 164 aligned with each other,and their longitudinal grooves 168 aligned with each other. Offsettingof the longitudinal ridges and the longitudinal grooves from each otheron adjacent segments promotes turbulence or mixing in blood flowing pastthe exterior of the heat transfer element 170. In other embodiments,they may be offset.

In addition, the rounded contours of the ridges 164 also allow the heattransfer element 160 to maintain a relatively atraumatic profile,thereby minimizing the possibility of damage to the blood vessel wall. Aheat transfer element 160 according to the present invention may becomprised of two., three, or more heat transfer segments 162.

FIG. 10 is a transverse section view of a heat transfer segment 180,illustrative of segment 162 of heat transfer element 160 shown in FIG.9. The coaxial construction of the heat transfer segment 180 is clearlyshown. The inner coaxial lumen 182 is defined by the insulating coaxialtube 184. The outer lumen 190 is defined by the exterior surface of theinsulating coaxial tube 184 and the interior surface 192 of the heattransfer segment 180. In addition, parallel longitudinal ridges 186 andparallel longitudinal grooves 188 may be seen in FIG. 10. Thelongitudinal ridges 186 and the longitudinal grooves 188 may have arelatively rectangular cross-section, as shown in FIG. 10, or they maybe more triangular in cross-section, as shown in FIG. 9. Thelongitudinal ridges 186 and the longitudinal grooves 188 may be formedonly on the exterior surface of the segment 180, with a cylindricalinterior surface 192. Alternatively, corresponding longitudinal ridgesand grooves may be formed on the interior surface 192 as shown, topromote turbulence or mixing in the working fluid. Although FIG. 10shows six ridges and six grooves, the number of ridges and grooves mayvary. Where a smooth exterior surface is desired, the outer tube of theheat transfer segment 180 could have smooth outer and inner surfaces,like the inner tube 184. Alternatively, the outer tube of the heattransfer segment 180 could have a smooth outer surface and a ridgedinner surface like the interior surface 192 shown in FIG. 10.

FIG. 11 is a cut-away perspective view of an alternative embodiment of aheat transfer element 194. An external surface 196 of the heat transferelement 194 is covered with a series of axially staggered protrusions198. The staggered nature of the outer protrusions 198 is readily seenwith reference to FIG. 12 which is a transverse cross-sectional viewtaken at a location denoted by the line 12-12 in FIG. 11. As the bloodflows along the external surface 196, it collides with one of thestaggered protrusions 198 and a turbulent wake flow is created behindthe protrusion. As the blood divides and swirls alongside of the firststaggered protrusion 198, its turbulent wake encounters anotherstaggered protrusion 198 within its path preventing the re-lamination ofthe flow and creating yet more mixing. In this way, the velocity vectorsare randomized and mixing is created not only in the boundary layer butalso throughout a large portion of the free stream. As is the case withthe preferred embodiment, this geometry also induces a mixing effect onthe internal working fluid flow.

A working fluid is circulated up through an inner lumen 200 defined byan insulating tube 202 to a distal tip of the heat transfer element 194.The working fluid then traverses an outer lumen 204 in order to transferheat to the exterior surface 196 of the heat transfer element 194. Theinside surface of the heat transfer element 194 is similar to theexterior surface 196 in order to induce turbulent or “mixed” flow of theworking fluid. The inner protrusions can be aligned with the outerprotrusions 198 as shown in FIG. 12 or they can be offset from the outerprotrusions 198 as shown in FIG. 11.

With reference to FIGS. 13 and 14, a catheter 206 constructed inaccordance with an alternative embodiment of the invention will now bedescribed. The catheter 206 includes an elongated catheter body 208 witha heat transfer element 210 located at a distal portion 212 of thecatheter body 208. The catheter 206 includes a multiple lumenarrangement 214 to deliver fluid to and from an interior 216 of the heattransfer element 210 and allow the catheter 206 to be placed into ablood vessel over a guidewire. The heat transfer element 210 includesturbulence-inducing invaginations 218 located on an exterior surface252. Similar invaginations may be located on an interior surface 220 ofthe heat transfer element 210, but are not shown for clarity. Further,it should be noted that the heat transfer element 210 is shown with onlyfour invaginations 218. Other embodiments may employ multiple elementsconnected by flexible joints or bellows as disclosed above. A singleheat transfer element is shown in FIG. 13 merely for clarity. In analternative embodiment of the invention, any of the other heat-transferelements described herein may replace heat transfer element 212.Alternatively, the multi-lumen arrangement may be used to deliver fluidto and from the interior of an operative element(s) other than aheat-transfer-element such as, but without limitation, a catheterballoon, e.g., a dilatation balloon.

The catheter 206 includes an integrated elongated multiple lumen membersuch as a bi-lumen member 222 having a first lumen member 226 and asecond lumen member 228. The bi-lumen member 222 has a substantiallyfigure-eight cross-sectional shape (FIG. 14) and an outer surface 224with the same general shape. The first lumen member 226 includes aninterior surface 230 defining a first lumen or guide wire lumen 232having a substantially circular cross-sectional shape. The interiorsurface 230 may be coated with a lubricious material to facilitate thesliding of the catheter 206 over a guidewire. The first lumen member 226further includes a first exterior surface 242 and a second exteriorsurface 244. The first lumen 232 is adapted to receive a guide wire forplacing the catheter 206 into a blood vessel over the guidewire in awell-known manner.

In FIGS. 13 and 14, the guide wire lumen 232 is not coaxial with thecatheter body 208. In an alternative embodiment of the invention, theguide wire lumen 232 may be coaxial with the catheter body 208.

The second lumen member 228 includes a first interior surface 246 and asecond interior surface 248, which is the same as the second exteriorsurface 244 of the first lumen member 226, that together define a secondlumen or supply lumen 250 having a substantially luniformcross-sectional shape. The second lumen member 228 further includes anexterior surface 252. The second lumen 250 has a cross-sectional areaA₂. The second lumen 250 is adapted to supply working fluid to theinterior of the heat transfer element 210 to provide temperature controlof a flow or volume of blood in the manner described above.

The second lumen member 228 terminates short of a distal end 236 of thecatheter 206, leaving sufficient space for the working fluid to exit thesupply lumen 250 so it can contact the interior surface 220 of the heattransfer element 210 for heat transfer purposes.

Although the second lumen member 228 is shown as a single supply lumenterminating adjacent the distal end 236 of catheter 206 to deliverworking fluid at the distal end of the catheter 206, with reference toFIG. 15, in an alternative embodiment of the invention, a single supplylumen member 254 may include one or more outlet openings 256 adjacentthe distal end 236 of the catheter 206 and one or more outlet openings258 adjacent a mid-point along the interior length of the heat transferelement 210. This arrangement improves the heat transfer characteristicsof the heat-transfer element 210 because fresh working fluid at the sametemperature is delivered separately to each segment 104, 106 of theinterior of the heat-transfer element 210 instead of in series.

Although two heat transfer segments 104, 106 are shown, it will bereadily apparent that a number of heat transfer segments other than two,e.g., one, three, four, etc., may be used.

It will be readily apparent to those skilled in the art that in anotherembodiment of the invention, in addition to the one or more openings 256in the distal portion of the heat transfer element 210, one or moreopenings at one or more locations may be located anywhere along theinterior length of the heat transfer element 210 proximal to the distalportion.

With reference to FIG. 16, in an alternative embodiment of theinvention, first and second supply lumen members 260, 262 definerespective first and second supply lumens 264, 266 for supplying workingfluid to the interior of the heat transfer element 210. The first supplylumen 260 terminates just short of the distal end 236 of the catheter206 to deliver working fluid at the distal portion of the heat transferelement 210. The second supply lumen 262 terminates short of the distalportion of the catheter 206, for example, at approximately a mid-lengthpoint along the interior of the heat transfer element 210 for deliveringworking fluid to the second heat transfer segment 104. In an alternativeembodiment of the invention, the second lumen member 262 may terminateanywhere along the interior length of the heat transfer element 210proximal to the distal portion of the heat transfer element 210.Further, a number of supply lumens 262 greater than two may terminatealong the interior length of the heat transfer element 210 fordelivering a working fluid at a variety of points along the interiorlength of the heat transfer element 210.

With reference back to FIGS. 13 and 14, the bitumen member 222 ispreferably extruded from a material such as polyurethane or Pebax. In anembodiment of the invention, the bitumen member is extrudedsimultaneously with the catheter body 208. In an alternative embodimentof the invention, the first lumen member 226 and second lumen member 228are formed separately and welded or fixed together.

A third lumen or return lumen 238 provides a convenient return path forworking fluid. The third lumen 238 is substantially defined by theinterior surface 220 of the heat transfer element 210, an interiorsurface 240 of the catheter body 208, and the exterior surface 224 ofthe bitumen member 222. The inventors have determined that the workingfluid pressure drop through the lumens is minimized when the third lumen238 has a hydraulic diameter D₃ that is equal to 0.75 of the hydraulicdiameter D₂ of the second lumen 250. However, the pressure drop thatoccurs when the ratio of the hydraulic diameter D₃ to the hydraulicdiameter D₂ is substantially equal to 0.75, i.e., 0.75±0.10, works well.For flow through a cylinder, the hydraulic diameter D of a lumen isequal to four times the cross-sectional area of the lumen divided by thewetted perimeter. The wetted perimeter is the total perimeter of theregion defined by the intersection of the fluid path through the lumenand a plane perpendicular to the longitudinal axis of the lumen. Thewetted perimeter for the return lumen 238 would include an inner wettedperimeter (due to the outer surface 224 of the bi-lumen member 222) andan outer wetted perimeter (due to the interior surface 240 of thecatheter body 208). The wetted perimeter for the supply lumen 250 wouldinclude only an outer wetted perimeter (due to the first and secondinterior surfaces 246, 248 of the bitumen member 222). Thus, the wettedperimeter for a lumen depends on the number of boundary surfaces thatdefine the lumen.

The third lumen 238 is adapted to return working fluid delivered to theinterior of the heat transfer element 210 back to an external reservoiror the fluid supply for recirculation in a well-known manner.

In an alternative embodiment, the third lumen 238 is the supply lumenand the second lumen 250 is the return lumen. Accordingly, it will bereadily understood by the reader that adjectives such as “first,”“second,” etc. are used to facilitate the reader's understanding of theinvention and are not intended to limit the scope of the invention,especially as defined in the claims.

In a further embodiment of the invention, the member 222 may include anumber of lumens other than two such as, for example, 1, 3, 4, 5, etc.Additional lumens may be used as additional supply and/or return lumens,for other instruments, e.g., imaging devices, or for other purposes,e.g., inflating a catheter balloon or delivering a drug.

Heating or cooling efficiency of the heat transfer element 210 isoptimized by maximizing the flow rate of working fluid through thelumens 250, 238 and minimizing the transfer of heat between the workingfluid and the supply lumen member. Working fluid flow rate is maximizedand pressure drop minimized in the present invention by having the ratioof the hydraulic diameter D₃ of the return lumen 238 to the hydraulicdiameter D₂ of the supply lumen 250 equal to 0.75. However, a ratiosubstantially equal to 0.75, i.e., 0.75±10-20%, is acceptable. Heattransfer losses are minimized in the supply lumen 250 by minimizing thesurface area contact made between the bitumen member 222 and the workingfluid as it travels through the supply lumen member. The surface area ofthe supply lumen member that the supplied working fluid contacts is muchless than that in co-axial or concentric lumens used in the past becausethe supplied working fluid only contacts the interior of one lumenmember compared to contacting the exterior of one lumen member and theinterior of another lumen member. Thus, heat transfer losses areminimized in the embodiments of the supply lumen in the multiple lumenmember 222 of the present invention.

It will be readily apparent to those skilled in the art that the supplylumen 250 and the return lumen 238 may have cross-sectional shapes otherthan those shown and described herein and still maintain the desiredhydraulic diameter ratio of substantially 0.75. With reference to FIGS.17 and 18, an example of a catheter 206 including a supply lumen and areturn lumen constructed in accordance with an alternative preferredembodiment of the invention, where the hydraulic diameter ratio of thereturn lumen to the supply lumen is substantially equal to 0.75 isillustrated. It should be noted, the same elements as those describedabove with respect to FIGS. 13 and 14 are identified with the samereference numerals and similar elements are identified with the samereference numerals, but with a (′) suffix.

The catheter 206 illustrated in FIGS. 17 and 18 includes a multiplelumen arrangement 214′ for delivering working fluid to and from aninterior 216 of the heat transfer element 210 and allowing the catheterto be placed into a blood vessel over a guide wire. The multiple lumenarrangement 214′ includes a bitumen member 222′ with a slightlydifferent construction from the bitumen member 222 discussed above withrespect to FIGS. 13 and 14. Instead of an outer surface 224 that isgenerally figure eight shaped, the bi-lumen member 222′ has an outersurface 224′ that is circular. Consequently, the third lumen 238′ has anannular cross-sectional shape.

As discussed above, maintaining the hydraulic diameter ratio of thereturn lumen 250′ to the supply lumen 238′ substantially equal to 0.75maximizes the working fluid flow rate through the multiple lumenarrangement 214′.

In addition, the annular return lumen 238′ enhances the convective heattransfer coefficient within the heat transfer element 210, especiallyadjacent an intermediate segment or bellows segment 268. Working fluidflowing through the annular return lumen 238′, between the outer surface224′ of the bitumen member 222′ and the inner surface 220 of the heattransfer element, encounters a restriction 270 caused by the impingementof the bellows section 268 into the flow path. Although the impingementof the bellows section 268 is shown as causing the restriction 270 inthe flow path of the return lumen 238′, in an alternative embodiment ofthe invention, the bitumen member 222′ may create the restriction 270 bybeing thicker in this longitudinal region of the bitumen member 222′.The distance between the bitumen member 222′ and the bellows section 268is such that the characteristic flow resulting from a flow of workingfluid is at least of a transitional nature.

For a specific working fluid flux or flow rate (cc/sec), the mean fluidvelocity through the bellows section restriction 270 will be greaterthan the mean fluid velocity obtained through the annular return lumen238′ in the heat transfer segment 104, 106 of the heat transfer element210. Sufficiently high velocity through the bellows section restriction270 will result in wall jets 272 directed into the interior portion 220of the heat transfer segment 104. The wall jets 272 enhance the heattransfer coefficient within the helical heat transfer segment 104because they enhance the mixing of the working fluid along the interiorof the helical heat transfer segment 104. Increasing the velocity of thejets 272 by increasing the working fluid flow rate or decreasing thesize of the restriction 270 will result in a transition closer to thejet exit and greater mean turbulence intensity throughout the helicalheat transfer segment 104. Thus, the outer surface 224′ of the bitumenmember 222′, adjacent the bellows 268, and the inner surface of thebellows 268 form means for further enhancing the transfer of heatbetween the heat transfer element 210 and the working fluid, in additionto that caused by the interior portion 220 of the helical heat transfersegment 104.

In an alternative embodiment of the invention, as described above, theheat transfer element may include a number of heat transfer segmentsother than two, i.e., 1, 3, 4, etc., with a corresponding number ofintermediate segments, i.e., the number of heat transfer segments minusone.

The embodiment of the multiple lumen arrangement 222 discussed withrespect to FIGS. 13 and 14 would not enhance the convective heattransfer coefficient as much as the embodiment of the multiple lumenarrangement 222′ discussed with respect to FIGS. 17 and 18 becauseworking fluid would preferentially flow through the larger areas of thereturn lumen 238, adjacent the junction of the first lumen member 226and second lumen member 228. Thus, high-speed working fluid would havemore contact with the outer surface 224 of the bi-lumen member 222 andless contact with the interior portion of 220 heat transfer element 210.In contrast, the annular return lumen 238′ of the multiple lumenarrangement 222′ causes working fluid flow to be axisymmetric so thatsignificant working fluid flow contacts all areas of the helical segmentequally.

On the other hand, the heat transfer element according to an embodimentof the present invention may also be made of a flexible material, suchas latex rubber. The latex rubber provides a high degree of flexibilitywhich was previously achieved by articulation. The latex rubber furtherallows the heat transfer element to be made collapsible so that whendeflated the same may be easily inserted into a vessel. Insertion andlocation may be conveniently made by way of a guide catheter or guidewire. Following insertion and location in the desired vessel, the heattransfer element may be inflated for use by a working fluid such assaline, water, perfluorocarbons, or other suitable fluids.

A heat transfer element made of a flexible material generally hassignificantly less thermal conductivity than a heat transfer elementmade of metal. The device compensates for this by enhancing the surfacearea available for heat transfer. This may be accomplished in two ways:by increasing the cross-sectional size and by increasing the length.Regarding the former, the device may be structured to be large wheninflated, because when deflated the same may still be inserted into anartery or vein. In fact, the device may be as large as the vessel wall,so long as a path for blood flow is allowed, because the flexibility ofthe device tends to prevent damage to the wall even upon contact. Suchpaths are described below. Regarding the latter, the device may beconfigured to be long. One way to configure a long device is to taperthe same so that the device may fit into distal vessels having reducedradii in a manner described below. The device further compensates forthe reduced thermal conductivity by reducing the thickness of the heattransfer element wall. In alternative embodiments, versions of thedevice use a heat transfer element design that produces a high level ofmixing or turbulence in the free stream of the blood and in the workingfluid. One embodiment of the invention forces a helical motion on theworking fluid and imposes a helical barrier in the blood, causingmixing. In an alternative embodiment, the helical barrier is tapered. Ina second alternative embodiment, a tapered inflatable heat transferelement has a shape or surface features to cause mixing or turbulence.As one example, the surface features may be a spiral shape. In anotherexample, the surface features may be staggered protrusions. In all ofthese embodiments, the design forces a high level of mixing in the freestream of the blood by causing the blood to navigate a tortuous pathwhile passing through the vessel. This tortuous path causes the blood toundergo violent accelerations resulting in turbulence.

In a third alternative embodiment of the invention, a taper of aninflatable heat transfer element provides enough additional surface areaper se to cause sufficient heat transfer. In all of the embodiments, theinflation is performed by the working fluid, such as water or saline.

Referring to FIG. 19, a side view is shown of a first embodiment of aheat transfer element 272 according to an embodiment of the invention.The heat transfer element 272 is formed by an inlet lumen 276 and anoutlet lumen 274. In this embodiment, the outlet lumen 274 is formed ina helix shape surrounding the inlet lumen 276 that is formed in a pipeshape. The names of the lumens are of course not limiting. It will beclear to one skilled in the art that the inlet lumen 276 may serve as anoutlet and the outlet lumen 274 may serve as an inlet. It will also beclear that the heat transfer element is capable of both heating (bydelivering heat to) and cooling (by removing heat from) a desired area.

The heat transfer element 272 is rigid but flexible so as to beinsertable in an appropriate vessel by use of a guide catheter.Alternatively, the heat transfer element may employ a device forthreading a guide wire therethrough to assist placement within anartery. The heat transfer element 272 has an inflated length of L, ahelical diameter of D_(c), a tubal diameter of d, and a helical angle ofα. For example, D_(c) may be about 3.3 mm and d may be about 0.9 mm to 1mm. Of course, the tubal diameter d need not be constant. For example,the diameter of the inlet lumen 276 may differ from that of the outletlumen 272.

The shape of the outlet lumen 274 in FIG. 19 is helical. This helicalshape presents a cylindrical obstacle, in cross-section, to the flow ofblood. Such obstacles tend to create turbulence in the free stream ofblood. In particular, the form of turbulence is the creation of vonKarman vortices in the wake of the flow of blood, downstream of thecylindrical obstacles.

Typical inflatable materials are not highly thermally conductive. Theyare much less conductive than the metallic heat transfer elementdisclosed in the Pat. incorporated by reference above. The difference inconductivity is compensated for in at least two ways in the presentdevice. The material is made thinner and the heat transfer element isafforded a larger surface area. Regarding the former, the thickness maybe less than about ½ mil for adequate cooling.

Thin inflatable materials, particularly those with large surface areas,may require a structure, such as a wire, within their interiors tomaintain their approximate uninflated positions so that upon inflation,the proper form is achieved. Thus, a wire structure 282 is shown in FIG.19 that may be advantageously disposed within the inflatable material toperform such a function.

Another consideration is the angle α of the helix. Angle a should bedetermined to optimize the helical motion of the blood around the lumens274 and 276, enhancing heat transfer. Of course, angle α should also bedetermined to optimize the helical motion of the working fluid withinthe lumens 274 and 276. The helical motion of the working fluid withinthe lumens 274 and 276 increases the turbulence in the working fluid bycreating secondary motions. In particular, helical motion of a fluid ina pipe induces two counter-rotating secondary flows.

An enhancement of h_(c) would be obtained in this system, and thisenhancement may be described by a Nusselt number Nu of up to about oreven more.

The above discussion describes one embodiment of a heat transferelement. An alternative embodiment of the device, shown in a side viewin FIG. 20, illustrates a heat transfer element 286 with a surface areaenhancement. Increasing the surface area of the inflatable materialenhances heat transfer. The heat transfer element 272 includes a seriesof coils or helices of different coil diameters and tubal diameters. Itis not strictly necessary that the tubal diameters differ, but it islikely that commercially realizable systems will have differing tubaldiameters. The heat transfer element 272 may taper either continuouslyor segmentally.

This alternative embodiment enhances surface area in two ways. First,the use of smaller diameter lumens enhances the overallsurface-to-volume ratio. Second, the use of progressively smaller (i.e.,tapered) lumens allows a distal end 312 to be inserted further into anartery than would be possible with the embodiment of FIG. 19.

In the embodiment of FIG. 20, a first coil segment 288 is shown havinglength L₁ and diameter D_(C1). The first coil segment 288 is formed ofan inlet lumen 296 having diameter d₁ and an outlet lumen 298 havingdiameter d₁′. In the first coil segment, as well as the others, theoutlet lumen need not immediately drain the inlet lumen. In FIG. 20, theinlet lumen for each segment feeds the inlet lumen of the succeedingsegment except for an inlet lumen adjacent a distal end 312 of the heattransfer element 286 that directly feeds its corresponding outlet lumen.

A separate embodiment may also be constructed in which the inlet lumenseach provide working fluid to their corresponding outlet lumens. In thisembodiment, either a separate lumen needs to be provided to drain eachoutlet lumen or each outlet lumen drains into the adjacent outlet lumen.This embodiment has the advantage that an opposite helicity may beaccorded each successive segment. The opposite helicities in turnenhance the turbulence of the working fluid flowing past them.

A second coil segment 290 is shown having length L₂ and diameter D_(C2).The second coil segment 290 is formed of an inlet lumen 300 havingdiameter d₂ and an outlet lumen 302 having diameter d₂′. A third coilsegment 292 is shown having length L₃ and diameter D_(C3). The thirdcoil segment 292 is formed of an inlet lumen 304 having diameter d₃ andan outlet lumen 306 having diameter d₃′. Likewise, a fourth coil segment294 is shown having length L₄ and diameter D_(C4). The fourth coilsegment 294 is formed of an inlet lumen 308 having diameter d₄ and anoutlet lumen 310 having diameter d₄′. The diameters of the lumens,especially that of the lumen located at or near distal end 312, shouldbe large enough to not restrict the flow of the working fluid withinthem. Of course, any number of lumens may be provided depending on therequirements of the user.

FIG. 21 shows the connection between two adjacent inlet lumens 296 and300. A joint 314 is shown coupling the two lumens. The construction ofthe joint may be by way of variations in stress, hardening, etc.

An advantage to this alternative embodiment arises from the smallerdiameters of the distal segments. The heat transfer element of FIG. 20may be placed in smaller workspaces than the heat transfer element ofFIG. 19. For example, a treatment for brain trauma may include placementof a cooling device in the internal carotid artery of a patient. Asnoted above, the common carotid artery feeds the internal carotidartery. In some patients, the heat transfer element of FIG. 19 may notfit in the internal carotid artery. Similarly, the first coil segment ofthe heat transfer element in FIG. 20 may not easily fit in the internalcarotid artery, although the second, third, and fourth segments may fit.Thus, in the embodiment of FIG. 20, the first coil segment may remain inthe common carotid artery while the segments of smaller diameter (thesecond, third, and fourth) may be placed in the internal carotid artery.In fact, in this embodiment, D_(C1) may be large, such as 5-6 mm. Theoverall length of the heat transfer element 286 may be, e.g., about 20to 25 cm. Of course, such considerations play less of a role when thedevice is placed in a large vein such as the inferior vena cava.

An additional advantage was mentioned above. The surface area of thealternative embodiment of FIG. 20 may be substantially larger than thatof the embodiment of FIG. 19, resulting in significantly enhanced heattransfer. For example, the enhancement in surface area may besubstantial, such as up to or even more than three times compared to thesurface area of the device of the application incorporated by referenceabove. An additional advantage of both embodiments is that the helicalrounded shape allows atraumatic insertion into cylindrical cavities suchas, e.g., arteries.

The embodiment of FIG. 20 may result in an Nu from 1 up to about 50.

FIG. 22 shows a second alternative embodiment of the device employingsurface features rather than overall shape to induce turbulence. Inparticular, FIG. 22 shows a heat transfer element 314 having an inletlumen (not shown) and an outlet inflatable lumen 328 having foursegments 316, 318, 320, and 330. Segment 346 is adjacent a proximal end326 and segment 330 is adjacent a distal end 322. The segments arearranged having reducing radii in the direction of the proximal end tothe distal end. In a manner similar to that of the embodiment of FIG.28, the feature of reducing radii allows insertion of the heat transferelement into small work places such as small arteries.

Heat transfer element 314 has a number of surface features 324 disposedthereon. The surface features 324 may be constructed with, e.g., varioushardening treatments applied to the heat transfer element 314, oralternatively by injection molding. The hardening treatments may resultin a wavy or corrugated surface to the exterior of heat transfer element314. The hardening treatments may further result in a wavy or corrugatedsurface to the interior of heat transfer element 314. FIG. 23 shows avariation of this embodiment, in which a fabrication process is usedwhich results in a spiral or helical shape to the surface features.

The embodiment of FIG. 22 may result in an Nu of about 1 to 50.

Of course, other surface features may also be used which result inturbulence in fluids flowing past them. These include spirals, helices,protrusions, various polygonal bodies, pyramids, tetrahedrons, wedges,etc.

In some situations, an enhanced surface area alone, without the creationof additional turbulence, may result in sufficient heat transfer to coolthe blood. Referring to FIG. 24, a heat transfer element 332 is shownhaving an inlet lumen 334 and an outlet lumen 336. The inlet lumen 334provides a working fluid to the heat transfer element 332 and outletlumen 336 drains the working fluid from the same. The functions may, ofcourse, be reversed. The heat transfer element 332 is further dividedinto five segments, although more or less may be provided as dictated byrequirements of the user. The five segments in FIG. 24 are denotedsegments 338, 340, 342, 344, and 346. In FIG. 24, the segment 338 has afirst and largest radius R₁, followed by corresponding radii forsegments 340, 342, 344, and 346. Segment 346 has a second and smallestradius. The length of the segment 338 is L₁, followed by correspondinglengths for segments 340, 342, 344, and 346.

A purely tapered (nonsegmented) form may replace the tapered segmentalform, but the former may be more difficult to manufacture. In eithercase, the tapered form allows the heat transfer element 332 to bedisposed in small arteries, i.e., arteries with radii smaller than R₁. Asufficient surface area is thus afforded even in very small arteries toprovide the required heat transfer.

The surface area and thus the size of the device should be substantialto provide the necessary heat transfer. Example dimensions for athree-segmented tapered form may be as follows: L₁=10 cm, R₁=2.5 mm;L₂=10 cm, R₂=1.65 mm, L₃=5 cm, R₃=1 mm. Such a heat transfer elementwould have an overall length of 25 cm and a surface area of 3×10-4 m².

The embodiment of FIG. 24 results in an enhancement of the heat transferrate of up to about 300% due to the increased surface area S alone.

A variation of the embodiment of FIG. 24 includes placing at least onemixing-inducing surface feature within the interior of the outlet lumen336. This surface feature may induce mixing in the working fluid,thereby increasing the convective heat transfer rate in the mannerdescribed above.

Another variation of the embodiment of FIG. 24 involves reducing thejoint diameter between segments (not shown). For example, the inflatablematerial may be formed such that joints 348, 350, 352, and 354 have adiameter only slightly greater than that of the inlet lumen 334. Inother words, the heat transfer element 332 has a tapered “sausage”shape.

In all of the embodiments, the inflatable material may be formed fromseamless and nonporous materials that are therefore impermeable to gas.Impermeability can be particularly important depending on the type ofworking fluid that is cycled through the heat transfer element. Forexample, the inflatable material may be latex or other such rubbermaterials, or alternatively of any other material with similarproperties under inflation. The flexible material allows the heattransfer element to bend, extend and compress so that it is more readilyable to navigate through tiny blood vessels. The material also providesfor axial compression of the heat transfer element that can limit thetrauma when the distal end of the heat transfer element 272 abuts ablood vessel wall. The material should be chosen to toleratetemperatures in the range of −1° C. to 37° C., or even higher in thecase of blood heating, without a loss of performance.

In these embodiments as well, it may be desirable to treat the surfaceof the heat transfer element to avoid clot formation because the heattransfer element may dwell within the blood vessel for extended periodsof time, such as 24-48 hours or even longer. One means by which toprevent thrombus formation is to bind an antithrombogenic agent to thesurface of the heat transfer element. For example, heparin is known toinhibit clot formation and is also known to be useful as a biocoating.

Referring back to FIG. 19, an embodiment of the method of the inventionwill be described. A description with reference to the other embodimentsis analogous. A guide catheter or wire may be disposed up to or near thearea to be cooled or heated. The heat transfer element may be fed overthe guide wire to the area. The movement of the heat transfer element ismade significantly more convenient by the flexibility of the heattransfer element as has been described above.

Once the heat transfer element 272 is in place, a working fluid such assaline or other aqueous solution may be circulated through the heattransfer element 272 to inflate the same. Fluid flows from a supplycatheter into the inlet lumen 276. At the distal end 280 of the heattransfer element 272, the working fluid exits the inlet lumen 276 andenters the outlet lumen 274.

In the case of the embodiment of FIG. 22, the working fluid exits theinlet lumen and enters an outlet inflatable lumen 328 having segments316, 318, 320, and 330. As the working fluid flows through the outletlumen 328, heat is transferred from the exterior surface of the heattransfer element 314 to the working fluid. The temperature of theexternal surface may reach very close to the temperature of the workingfluid because the heat transfer element 314 is constructed from verythin material.

The working fluids that may be employed in the device include water,saline or other fluids that remain liquid at the temperatures used.Other coolants, such as freon, undergo nucleated boiling and may createturbulence through a different mechanism. Saline is a safe coolantbecause it is non-toxic and leakage of saline does not result in a gasembolism that may occur with the use of boiling refrigerants.

By enhancing turbulence in the coolant, the coolant can be delivered tothe heat transfer element at a warmer temperature and still achieve thenecessary heat transfer rate. In particular, the enhanced heat transfercharacteristics of the internal structure allow the working fluid to bedelivered to the heat transfer element at lower flow rates and lowerpressures. This is advantageous because high pressures may stiffen theheat transfer element and cause the same to push against the wall of thevessel, thereby shielding part of the heat transfer unit from the blood.Such pressures are unlikely to damage the walls of the vessel because ofthe increased flexibility of the inflated device. The increased heattransfer characteristics allow the pressure of the working fluid to bedelivered at pressures as low as 5 atmospheres, 3 atmospheres, 2atmospheres or even less than 1 atmosphere. In a preferred embodiment,the heat transfer element creates a turbulence intensity greater than0.05 in order to create the desired level of turbulence in the entireblood stream during the whole cardiac cycle. The turbulence intensitymay be greater than 0.055, 0.06, 0.07 or up to 0.10 or 0.20 or evengreater.

As shown in FIG. 25, in another embodiment of the invention. the coolingapparatus 368 of the present invention includes a flexible multilumencatheter 370, an inflatable balloon 372, and a plurality of blood flowpassageways 16 through the balloon 372. The balloon 372 is shown in aninflated state, in a selected position in a common carotid artery CC.

The balloon 372 is attached near a distal end of the flexible catheter370. The catheter 370 can have at least a cooling fluid supply lumen 380and a cooling fluid return lumen 382, with the cooling fluid supplylumen 380 preferably being located substantially within the coolingfluid return lumen 382. The catheter 370 can also have a guidewire lumen384, for the passage of a guidewire 386, as is known in the art.

The balloon 372 can be formed from a flexible material, such as apolymer. The balloon 372 can be constructed to assume a substantiallycylindrical shape when inflated, with a proximal aspect 374 and a distalaspect 378. The balloon 372 can have a plurality of tubular shaped bloodflow passageways 376 formed therethrough, from the proximal aspect 374to the distal aspect 378. The tubular walls of the passageways 376constitute a heat transfer surface, for transferring heat from the bloodto the cooling fluid. The flexible material of the tubular passageways376 can be, at least in part, a metallized material, such as a filmcoated with a thin metal layer, either internally, externally, or both,to aid in heat transfer through the passageway walls. Alternatively, thetubular passageways 376 can be constructed of a metal-loaded polymerfilm. Further, the remainder of the balloon 372 can be coated with athin metallized layer, either internally, externally, or both, or ametal-loaded polymer film. The proximal aspect 374 and the distal aspect378 of the balloon can also constitute a heat transfer surface, fortransferring heat from the blood to the cooling fluid. The guidewirelumen 384 of the catheter 370 can also pass through the balloon 372,from the proximal aspect 374 to the distal aspect 378.

As shown in FIG. 26, each tubular passageway 376 has a proximal port 388in a proximal face 390 on the proximal aspect 374 of the balloon 372,and a distal port 392 in a distal face 394 on the distal aspect 378 ofthe balloon 372. A cooling fluid supply port 396 near the distal end ofthe cooling fluid supply lumen 380 supplies chilled saline solution froma chiller (not shown) to the interior of the balloon 372, surroundingthe blood flow passageways 376. A cooling fluid return port 398 in thecooling fluid return lumen 382 returns the saline solution from theinterior of the balloon 372 to the chiller. Relative placement of thecooling fluid ports 396, 398 can be chosen to establish flow counter tothe direction of blood flow, if desired.

FIG. 27 shows the proximal aspect 402 of the balloon 372 and gives aview through the blood flow passageways 376, illustrating the generalarrangement of the blood flow passageways 376, cooling fluid supplylumen 380, cooling fluid return lumen 382, and guidewire lumen 384,within the outer wall 400 of the balloon 372.

FIG. 28 is a side elevation view of the apparatus 368, with a partiallongitudinal section through the balloon wall 400, showing one possiblearrangement of the cooling fluid supply port 396 and the cooling fluidreturn port 398 within the balloon 372.

In practice, the balloon 372, in a deflated state, is passed through thevascular system of a patient on the distal end of the catheter 370, overthe guidewire 386. Placement of the guidewire 386 and the balloon 372can be monitored fluoroscopically, as is known in the art, by use ofradiopaque markers (not shown) on the guidewire 386 and the balloon 372.When the balloon 372 has been positioned at a desired location in thefeeding artery of a selected organ, such as in the common carotid arteryfeeding the brain, fluid such as saline solution is supplied through thecooling fluid supply lumen 380. This fluid passes through the coolingfluid supply port 396 into the interior of the balloon 372, surroundingthe tubular passageways 376, to inflate the balloon 372. Although theballoon 372 can be formed to assume a substantially cylindrical shapeupon unconstrained inflation, the balloon 372 will essentially conformto the shape of the artery within which it is inflated. As the balloon372 inflates, the blood flow passageways 376 open, substantiallyassuming the tubular shape shown.

When the balloon 372 has been properly inflated, blood continues to flowthrough the feeding artery CC by flowing through the blood flowpassageways 376, as indicated, for example, by the arrows in FIG. 25.The size and number of the blood flow passageways 376 are designed toprovide a desired amount of heat transfer surface, while maintaining asuitable amount of blood flow through the feeding artery CC. Return flowto the chiller can be established, to allow flow of cooling fluidthrough the cooling fluid return port 398 and the cooling fluid returnlumen 382 to the chiller. This establishes a continuous flow of coolingfluid through the interior of the balloon 372, around the blood flowpassageways 376. The return flow is regulated to maintain the balloon372 in its inflated state, while circulation of cooling fluid takesplace. The saline solution is cooled in the chiller to maintain adesired cooling fluid temperature in the interior of the balloon 372, toimpart a desired temperature drop to the blood flowing through thetubular passageways 376. This cooled blood flows through the feedingartery to impart the desired amount of cooling to the selected organ.Then, cooling fluid can be evacuated or released from the balloon 372,through the catheter 370, to deflate the balloon 372, and the apparatus368 can be withdrawn from the vascular system of the patient.

Temperature Sensing

A guidewire may also be employed to assist in installing the device. Thetip of the guidewire may contain or be part of a temperature monitor.The temperature monitor may be employed to measure the temperatureupstream or downstream of the heat transfer element and catheter,depending on the direction of blood flow relative to the temperaturemonitor. The temperature monitor may be, e.g., a thermocouple orthermistor.

An embodiment of the invention may employ a thermocouple which ismounted on the end of the guidewire. For the temperatures considered inblood heating or cooling, most of the major thermocouple types may beused, including Types T, E, J, K, G, C, D, R, S, B.

In an alternative embodiment, a thermistor may be used which is attachedto the end of the guidewire. Thermistors are thermally-sensitiveresistors (or “RTD”s, resistance temperature devices) whose resistancechanges with a change in body temperature. The use of thermistors may beparticularly advantageous for use in temperature-monitoring of bloodflow past cooling devices because of their sensitivity. For temperaturemonitoring of body fluids, thermistors that are mostly commonly usedinclude those with a large negative temperature coefficient ofresistance (“NTC”). These should ideally have a working temperaturerange inclusive of 25° C. to 4° C. Potential thermistors that may beemployed include those with active elements of polymers or ceramics.Ceramic thermistors may be most preferable as these may have the mostreproducible temperature measurements. Most thermistors of appropriatesizes are encapsulated in protective materials such as glass. The sizeof the thermistor, for convenient mounting to the guidewire and forconvenient insertion in a patient's vasculature, may be about or lessthan 15 mils. Larger thermistors may be used where desired. Of course,various other temperature-monitoring devices may also be used asdictated by the size, geometry, and temperature resolution desired.

A signal from the temperature-monitoring device may be fed back to thesource of working fluid to control the temperature of the working fluidemerging therefrom. In particular, a catheter may be connected to asource of working fluid. A proximal end of a supply lumen defined by asupply tube is connected at an output port to the source of workingfluid. The return lumen defined by a return tube is similarly connectedat an input port to the source of working fluid. The source of workingfluid can control the temperature of the working fluid emerging from theoutput port. A signal from a circuit may be inputted to the source ofworking fluid at an input. The signal from the circuit may be from thethermocouple, or may alternatively be from any other type oftemperature-monitoring device, such as, as noted above, at the tip ofthe guidewire.

The signal may advantageously be employed to alter the temperature, ifnecessary, of the working fluid from the source. For example, if thetemperature-monitoring device senses that the temperature of the bloodflowing in the vessel of the patient's vasculature is below optimal, asignal may be sent to the source of working fluid to increase thetemperature of the working fluid emerging therefrom. The opposite may beperformed if the temperature-monitoring device senses that thetemperature of the blood flowing in the feeding vessel of the patient'svasculature is above optimal.

Console

With reference to FIG. 29, an embodiment of a console system 544includes a heat transfer catheter 546, a control system 548, and acirculation set 550 housed by the control unit system 548. The controlsystem 548 may be equipped with an output display 552 and input keys 554to facilitate user interaction with the control system 548. A hood 556may be pivotally connected to a control unit housing 558 for coveringmuch of the circulation set 550.

Circulation Set

With reference to FIGS. 29 and 30, an embodiment of the circulation set550 will now be described. The circulation set 550 include one or moreof the following: a fluid reservoir 574, a pump 576, a filter 578, aheat exchanger 580, a temperature and pressure sensor assembly 584, asupply line 586, and a return line 588. A supply lumen port 570 and areturn lumen port 572 are coupled to respective supply lines 586 andreturn lines 588 of the circulation set 550. The supply line 586 andreturn line 588 are preferably comprised of one or more pieces oftubing, connectors, etc. for joining the aforementioned components ofthe circulation set 550 to the supply lumen port 570 and return lumenport 572. The circulation set 550 may supply, filter, circulate, and/orbe used to monitor the temperature and pressure of the heat transferfluid for the catheter 546

Temperature Monitoring

Closed loop control of thermal therapy such as that provided by thesystem requires feedback of a temperature signal which represents thestate of the patient, human or animal, to which the therapy is applied.This signal, combined with the target temperature of the therapy, servesas an input to a PID type control algorithm which regulates the energyadded to or removed from the patient.

In such a system, the servo gain may be set to deliver maximum systempower with approximately a 0.2 C servo error. With a PID controller,having zero coefficients for the integral and derivative terms, thecontroller may provide a proportional linear drive signal from 0% power,with a servo error=0° C., to 100% power with a servo error of 0.2 C. ormore.

Choosing the correct physiologic site for acquisition of this feedbacksignal is important to the success of the therapy. Since the thermalmodifications induced by the system are applied directly to the core ofthe patient, the control signal should ideally represent the thermalstate (temperature) of the core compartment. With current clinicallyaccepted temperature monitoring practice, core temperature is availablethrough esophageal or naso-esophageal, tympanic, bladder, or rectalprobes. While any of these may represent the temperature of a patient inequilibrium with the environment (i.e. one not subject to rapidtemperature change), certain locations, such as bladder and rectaltemperatures, described in more detail below, have been shown to lag theresponse of the core during intervals of rapid core temperature change.Additionally, esophageal, naso-esophageal, and tympanic probes may beacceptable for use in heavily sedated patients but are uncomfortable orotherwise impractical for use in lightly sedated or awake patients. Insome instances, monitoring temperature in the distal esophagus isappropriate for monitoring core body temperature of a patient and forproviding temperature feedback for controlling the induction andmaintenance of hypothermia. However, for some patients, including strokeand AMI patients, esophageal temperature monitoring is not practical asthese patients are often awake.

Other monitoring sites may be employed, including tympanic and bladder.However, even these monitoring sites are not ideal. For example, atympanic temperature probe may cause patient discomfort and may bepulled out during the monitoring period. If this happens, the systemwill turn off as the patient temperature is already being measured ashypothermic at room temperature. The bladder temperature probe does notrepresent in real time the dynamic temperature changes that areoccurring in the core. There is a significant lag of time, such as a 20to 40 minute delay, and an effect of 1 to 2° C. that may make the samenot represent the true core temperature.

Thus, to induce and control hypothermia in an awake patient requires amore reliable and accurate monitoring site that is not too invasive. Apulmonary artery (PA) temperature sensor located in a Swan-Ganzpulmonary artery catheter could be a reliable temperature site, but thisrequires another invasive catheter procedure, which is not indicated forstroke patients. Alternatively, a central venous catheter could measurethe temperature of the blood entering the right atrium, but again thismay be too invasive.

A sensor mounted on the interior of the catheter would address both ofthese problems by eliminating the need for a separate invasivetemperature probe and ensuring accurate control temperature measurementdue to the central placement of the catheter in the IVC. Since thetemperature inside the catheter and its external environment maytypically differ by 10-40° C. during operation, due to the presence ofwarm or cold heat transfer fluid within the catheter, acquisition of anaccurate control temperature from a catheter mounted probe, such as athermistor, may involve temporary cessation of therapy by halting theflux of heat transfer fluid. After the flux of heat transfer fluid ishalted, a finite interval may elapse before thermal equilibration orrelaxation of the catheter with its environment. Interrupting therapyfor acquisition of the control temperature may tend to reduce theaccuracy of the controller. A predictive algorithm allows computation ofa useful control temperature which does not require waiting for completeequilibration and thus measurement of patient core temperature. Onemethod for prediction of the equilibrium temperature, based on anassumed functional form for the relaxation history, is presented below.

In one embodiment, as an initial calculation, by measuring thetemperature of the catheter working fluid returning to the console, onecan determine or estimate the power delivered or consumed by thecatheter's heat exchanger.

For example,P _(delivered to catheter)=(T _(R) −T _(s))·(flow rate)·4.17W−°C.−cc/sec

This power is directly affected by the patient's temperature. Less poweris delivered with a warmer core temperature than a colder one. Ingeneral, the power delivered is proportional to the temperature gradientbetween the patient's blood temperature and the temperature of the heatexchanger:P _(delivered) (Watts)∝f(T _(patient),)

Going from a patient temperature of 37° C. to 33° C. would lower thepower approximately

${1 - \frac{33 - {4{^\circ}\mspace{14mu}{C.}}}{37 - {4{^\circ}\mspace{14mu}{C.}}}} \cong {12.1\%}$

Thus, by monitoring the decrease or increase in power applied orabsorbed by the catheter, one can estimate a useful control temperature,or at least the blood temperature, indirectly. By knowing the startingpatient temperature (e.g., the clinician could enter a valuecorresponding to the patient temperature via an IR ear thermometer) andprogramming in a desired patient temperature, the device couldcontrollably cool or heat the patient. By monitoring the returntemperature change, the instrument could control to the desiredhypothermic state.

Referring to FIG. 31, the console 750 may measure the temperature of thecatheter “coolant” or working fluid in both directions: i.e., thetemperature of the fluid 752 being supplied Ts to the catheter and thetemperature of the fluid 754 returning from the catheter TR. Thistemperature may be measured at the console 750 via, e.g., thermistorpins that interface with a disposable circulation set.

Another way to measure the latter temperature, e.g., the cathetercoolant return temperature, is to mount a temperature sensor 756 in thecatheter heat transfer element 758 in the return lumen 760 of thecatheter (see FIG. 32). This may yield a more precise measurement.

FIG. 33, described in more detail below, shows an alternate embodimentwhere a distal-tip-mounted temperature sensor is employed. By measuringthe coolant return temperature T_(R) in the catheter at the HTE, one canmeasure the instantaneous power absorbed or delivered to the bloodstream. This power may be proportional to the actual blood temperature.In the cooling mode, as the blood temperature decreases, the powerdelivered to the catheter decreases since the temperature gradient isless. This is also true, in the converse sense, in the rewarming mode.As the patient warms, less power is delivered to the blood stream. Thisrelationship can be approximated by

$\underset{{absorbed}/{delivered}}{\Delta\;{power}} \cong \frac{T_{{patient}_{1}} - T_{{bath}_{1}{return}}}{T_{{patient}_{2}} - T_{{bath}_{2}{return}}}$$T_{{patient}_{N}} = \begin{matrix}{{{patient}\mspace{14mu}{blood}\mspace{14mu}{temperature}\mspace{14mu}{near}}\mspace{11mu}} \\{{{catheter}\mspace{14mu}{heat}\mspace{14mu}{exchanger}\mspace{14mu}{at}\mspace{14mu}{time}\mspace{14mu} N}\;}\end{matrix}$ ${T_{{bath}_{N}}{return}} = \begin{matrix}\underset{{({console})}\mspace{11mu}{at}\mspace{14mu}{time}\mspace{14mu} N\mspace{14mu}{or}\mspace{14mu}{as}\mspace{14mu}{measured}\mspace{14mu}{at}\mspace{14mu}{the}}{{Temperature}\mspace{14mu}{of}\mspace{14mu}{coolant}\mspace{14mu}{returning}} \\\underset{{catheter}\mspace{14mu}{heat}\mspace{14mu}{exchanger}}{{to}\mspace{14mu}{the}\mspace{14mu}{heat}\mspace{14mu}{exchanger}}\end{matrix}$

The console 750 can measure the instantaneous power that is beingdelivered or absorbed by the catheter 762, and by monitoring the changein power delivered as cooling or warming is being administered, one canpredict or estimate a new control temperature value if the originaltemperature is known. Therefore, the following relationship exists:New control temperature estimate αf(initial blood temperature, initial power, current power)

This relationship may have other sensitivities which alter “the changein catheter power” to “change in blood temperature” relationship. Forexample, if the blood flow changes dramatically during this period, thecatheter heat exchanger efficiency may change. Higher cardiac outputswould allow for more power absorption or delivery.

To correct for this effect, the catheter coolant flow can be stopped andthe HTE can come to equilibrium with the blood temperature. At thisequilibrium, the temperature sensor on the HTE would be measuring thetemperature of the blood. This measurement may be used to correct theestimate for future blood temperature predictions. A determination maythen be performed as to how often it is necessary to stop the pump andrecalibrate the algorithm that provides real time blood temperatureestimates.

where:

T_(S)=Temperature of the coolant entering catheter

T_(R)=Temperature of the coolant returning from the catheter

T_(B)=Temperature of the blood indirectly estimated by turning off theflow of coolant in the catheter.

This method estimates the blood temperature between the “pump off”states and the run states.

Certain variables require a certain level of estimation. First, the pumpneeds to be “off” a set period of time to reach equilibrium with theblood flowing around the HTE.

For example, it may take 60 seconds to 120 seconds for the HTE outletsensor to achieve a temperature equilibrium with the flowing blood.

In addition, an estimation algorithm can be employed to predict thesteady state temperature. For example, referring to FIG. 34, thetemperature measured by a catheter-mounted thermistor at a time of fullpump activity may be, e.g., 10° C., at time t=0. If at this time thepump is turned off, the temperature as measured rises according to curve766 up to an equilibrium temperature. If at time t=1 the pump is turnedback on, then the temperature cools again according to curve 768. A dutycycle may be defined by:

${{duty}\mspace{14mu}{cycle}} = \frac{{{pump}\mspace{11mu}'}{{on}\;'}\mspace{14mu}{time}}{{{{pump}\mspace{14mu}'}\;{{on}\;'}\mspace{14mu}{time}} + {{{pump}\mspace{14mu}'}\;{{off}\;'}\mspace{14mu}{time}}}$

A good duty cycle may be, e.g., >90%.

The duty cycle can be enhanced, i.e., >90%, if a predictive algorithm isemployed to shorten the time that the pump is off. Referring to FIG. 35,an algorithm that predicts the control temperature allows themeasurement of temperature to occur in a shortened span of time, thusshortening the pump “off” time and raising the duty cycle. The followingexample demonstrates the principle that the patient temperature can bealtered, at least for a predetermined time, without constantlymonitoring the patient temperature.

The patient core temperature can move somewhat during periods of maximumdrive by the system. For example, it has been seen that an averagecooling rate may be 5° C./hr and an average warming rate may be 2°C./hr. Assuming these values, in 10 minutes, the body temperature canchange

Δ 0.8° C. cool down/10 minutes and

Δ 0.3° C. warmup/10 minutes

After this initial interval, e.g., 10 minutes, the algorithm may samplemore rapidly as it nears to the desired target value. For instance, ifthe patient initial temperature is 37° C. and the goal is 33° C., a 4°C. change, the device can anticipate that a minimum of 30 minutes to 45minutes will be required to induce a 4° C. core temperature change.Thus, the device can start cooling with maximum power for 30 minutes,then stop the pump and check the temperature.

As the temperature nears the set point, sampling may be more frequent.Table I shows a sample sampling algorithm that changes the frequency ofstopping the pump and measuring temperature as the temperaturedifference between patient target temperature and projected control orprojected or measured blood temperature is lowered. Tables III and IVshow more detailed analysis of the rates.

Temperature Sensor Located Within the HTE

EXAMPLE 1 Adjacent-Proximal-Bond-Mounted

Referring back to FIG. 32, a thermocouple 756, such as a “T” type, wasbonded into the proximal bond 764 of the catheter's HTE 762 (e.g., a 14fr. HTE). With the system running in the maximum cooling phase, the HTEsensor 756 was measuring a temperature of approximately 18° C. Uponstopping the circulation pump, the sensor's temperature roseexponentially to 37.4° C., with a time constant of approximately 10 to12 seconds. The actual temperature read as a function of time is as perTable II.

As may be seen, stopping the pump for 30 seconds, the temperature sensorapproached to approximately 0.3° C. of the final temperature. Stoppingthe pump for 20 seconds, the sensor will be short about 0.7° C. of thefinal value.

EXAMPLE 2 Tip-Mounted

Referring to FIG. 33, a catheter heat transfer tip assembly 800 is shownhaving a catheter tube 802 and a heat transfer tip 804 that are bondedtogether at a proximal bond 806. The assembly 800 includes a supplylumen 808 and a return lumen 810. Fluid within supply lumen 808 is inpressure communication with fluid within return lumen 810 via a skive812. The directions of fluid flow are indicated by the arrows withinlumens 808 and 810, although of course these may be reversed if desired.A guidewire lumen 814 may be disposed adjacent the supply lumen 808.

A thermocouple or thermistor assembly 816 may be disposed at or adjacentthe distal tip of the heat transfer tip, such as by being bonded to theexterior of the guidewire lumen 814. The assembly 816 may include athermistor or thermocouple 818, which may be encapsulated with a polymersleeve 820 such as polyimide or polyethylene. Instead of oradditionally, an encapsulation with a UV curable loctite adhesive (notshown) may take place. Finally, for strength, the encapsulated sensormay be placed into a hypotube 822, which may be a small stainless steeltube.

Sensor wires 824 may communicate signals from the temperature sensor tothe control circuitry. As the wires are typically too large to fit inthe return lumen 810, principally due to the bellows of the heattransfer tip, the same may traverse from the return lumen 810 (wherethey are disposed proximal of the proximal bond 806) to the supply lumen808 (where they are disposed distal of the proximal bond 806). Thistraversal may occur at an entry point 826, which is generally a hole.This arrangement has an additional benefit that the wires are out of thehigh pressure supply lumen for most of their length.

EXAMPLE 3 Sheath-Mounted

In yet another embodiment, the temperature sensor may be mounted on theintroducer sheath used for catheter installation. In this case, thetemperature sensor would be disposed on a part of the sheath that iswithin the vascular system.

EXAMPLE 4 Balloon-Mounted

In yet another embodiment, the temperature sensor may be mounted on aportion of the helical balloon embodiment disclosed above. For example,the same may be mounted on the exterior of the balloon at the distaltip, to achieve a temperature reading most indicative of core bodytemperature. However, for convenience, the temperature sensor may alsobe mounted at various other locations, either on or within the balloon.In any case, the sensor may have a polymer shield and/or metallic shielddiscussed above. As in the other embodiments, flow may be interruptedfor a short period of time to allow the temperature measured by thesensor to begin to relax to an equilibrium temperature, and from thetemperatures measured during this relaxation a projection to measure acontrol temperature may be made.

Predictive Algorithm

Determination of Time Constant

The time constant of the response is proportional to the trapped volumeof saline in the HTE. A 24 cm 14 fr. HTE will contain approximately thefollowing amount of saline:

$\frac{14\mspace{14mu}{{fr}.}}{\begin{matrix}{{\Pi\mspace{11mu} r^{2} \times l} \cong \;{{saline}\mspace{14mu}{volume}}} \\{{\Pi\mspace{11mu}\left( {0.23^{2}\mspace{14mu}{cm}^{2}} \right) \times 24\mspace{14mu}{cm}} \cong {4\mspace{14mu}{cm}^{3}}}\end{matrix}}$

A 24 cm 9 fr. HTE will contain approximately the following amount ofsaline:

$\frac{9\mspace{14mu}{{fr}.}}{V} = {{\Pi \times r^{2} \times l} = {{\Pi\mspace{11mu}\left( {0.15^{2}{cm}^{2}} \right) \times 24\mspace{14mu}{cm}} = {1.7\mspace{14mu}{cm}^{3}}}}$

Therefore, the time constant of a 9 fr. dual element HTE should be

$\frac{1.7}{4} = {{42.5\%\mspace{14mu}{of}\mspace{14mu}{the}\mspace{14mu} 14\mspace{14mu}{{fr}.}} \approx {4\mspace{14mu}{to}\mspace{14mu} 5\mspace{14mu}{seconds}}}$

Thus, for a 9 fr. catheter, the “pump off” time can be reduced toapproximately 10 seconds to 15 seconds.

EXAMPLE PROCEDURE

-   -   1. Input the desired “target temperature” and rate if desired.    -   2. Estimate patient temperature from HTE sensor={circumflex over        (T)}_(P) _((O)) pump “off” for e.g., 30 seconds.    -   3. Device calculates “servo error”        {circumflex over (T)} _(patient) _((O)) −T _(Target) _((O))        =E(O).    -   4. Device determines time interval to cool or warm, depending on        size of E(O) (see Table V).    -   5. Stop pump at the end of the heating/cooling interval.    -   6. Capture temperature data from HTE sensor at, e.g., 0.1 second        sampling rates        -   9 fr capture 15 seconds of data        -   14 fr. capture 30 seconds of data    -   7. Estimate control temperature and display value. Input this        value to the temperature control servo loop.    -   8. Start pump up depending on servo error (see Table VI):        where ServoError={circumflex over (T)} _(patient(N))−T        _(Target(O))

Alternatively, the pump power can be made proportional to the servoerror.

An alternative method for determining the interval to drive the systembefore stopping the pump is as follows:

-   -   Assuming    -   T_(o)(t)=Starting patient temperature; and    -   T_(T)=Target temperature,    -   The maximum rate of cooling or heating

$\left| \frac{\left\lbrack {{T_{o}(t)} - \left( {T_{t} + {0.5{^\circ}}} \right)} \right\rbrack}{R_{\max}\;{^\circ}\mspace{14mu}{{C.}/\min}} \right| = {{Time}\mspace{14mu}{minutes}}$

One approach to determining a projected control temperature is asfollows. Referring to FIG. 36, the exponential T(t) is shown. Area A1 isthe area under T(t) during the first 10 seconds and Area A2 is the areaunder T(t) during the next 10 seconds.

If the assumption is made that

${{\frac{A\; 1}{A\; 2} = {\frac{{Area}\mspace{14mu} 1{st}\mspace{14mu} 10\mspace{14mu}{Seconds}}{{Area}\mspace{14mu} 2{nd}\mspace{14mu} 10\mspace{14mu}{Seconds}} \propto B}},}\;$a time constant; independent of A

$\frac{A\; 1}{A\; 2} = \left. \frac{\int_{0}^{10}{A\left( {1 - {\mathbb{e}}^{- \frac{t}{B}}} \right)}}{\int_{10}^{20}{A\left( {1 - {\mathbb{e}}^{- \frac{t}{B}}} \right)}}\Rightarrow\frac{{\int_{0}^{10}1} - {\int_{0}^{10}{\mathbb{e}}^{- \frac{t}{B}}}}{{\int_{0}^{20}1} - {\int_{0}^{20}{\mathbb{e}}^{- \frac{t}{B}}}} \right.$$\frac{A\; 1}{A\; 2} = {\frac{10 + {Be}^{- \frac{10}{B}} - {Be}^{- \frac{0}{B}}}{10 + {Be}^{- \frac{20}{B}} - {Be}^{- \frac{10}{B}}} =}$

Defining a unique relationship between

${\frac{A\; 1}{A\; 2} = {f(B)}};$for every B, there is a well defined A1/A2 ratio

$\frac{A\; 1}{A\; 2} = \frac{10 + {Be}^{\frac{- 10}{B}} - B}{10 + {Be}^{\frac{- 20}{B}} - {Be}^{\frac{- 10}{B}}}$

A1 and A2 can be measured numerically. From this, B can be calculated.Of course, a look-up table can be instituted for ease of reference (seeTable VII). Also see FIG. 37, in which each area A1 and A2 encompass 12seconds sampling time.

Once B is determined from the look up table, A can be calculated asfollows:

${{A\; 1} + {A\; 2}} = {A\left\lbrack {{\int_{0}^{10}\left( {1 - {\mathbb{e}}^{- \frac{t}{B}}} \right)} + {\int_{0}^{20}\left( {1 - {\mathbb{e}}^{- \frac{t}{B}}} \right)}} \right\rbrack}$$A = \frac{{A\; 1} + {A\; 2}}{20 + {Be}^{- \frac{20}{B}} - B}$

The magnitude of correction can then be calculated.

$\begin{matrix}{{T(t)} = {T_{B} + {A\left( {1 - {\mathbb{e}}^{{- t}/B}} \right)}}} \\{{{{{Temperature}\mspace{14mu}{T(t)}\mspace{14mu}{at}\mspace{14mu}{end}\mspace{14mu}{of}\mspace{14mu} A\; 1} + \;{A\; 2}},{t = 20}}\;} \\{{T(20)} = {T_{B} + {\hat{A}\left( {1 - {\mathbb{e}}^{{- 20}/\hat{B}}} \right)}}} \\{at} \\{{T(\infty)} = {T_{B} + \hat{A}}} \\{or} \\{{T(\infty)} = {{T(20)} + {\Delta\; T\mspace{14mu}{correction}}}} \\{{\Delta\; T\mspace{11mu}{correction}} = {\hat{A}\;{\mathbb{e}}^{{- 20}/\hat{B}}}} \\{{@t} = 20} \\{{{\hat{T}\;\infty} = {{T(20)} + {\hat{A}\;{\mathbb{e}}^{{- 20}/\hat{B}}}}}\;}\end{matrix}$

Estimated final value

Referring to FIG. 38, which changes the above to the case where A1 andA2 encompassing non-equal time periods but equal areas:

$\begin{matrix}{{A\; 1} = {{\int_{0}^{12}{\left( {1 - {\mathbb{e}}^{{- t}/B}} \right)\ {\mathbb{d}t}}} = {{{\int_{0}^{12}{\mathbb{d}t}} - {\int_{0}^{12}{{\mathbb{e}}^{{- t}/B}{\mathbb{d}t}}}} = {12 + {B\;{\mathbb{e}}^{{- 12}/B}} - B}}}} \\{\mspace{31mu}{= {{12 + {12{\mathbb{e}}^{- 1}} - 12} = {{12 - 0.367} = 4.4}}}} \\{{A\; 1} = {4.4{^\circ}\mspace{14mu}{C.\mspace{11mu}{- \mspace{11mu}\sec}}}} \\{{A\; 2} = {{\int_{12}^{x}{\left( {1 - {\mathbb{e}}^{{- t}/B}} \right)\ {\mathbb{d}t}}} = {{{\int_{12}^{x}{\mathbb{d}t}} - {\int_{12}^{x}{{\mathbb{e}}^{{- t}/B}{\mathbb{d}t}}}} = {\left( {x - 12} \right) + {B\;{\mathbb{e}}^{{- x}/B}} - {Be}}}}} \\{{A\; 2} = {x - 12 + {B\left( {{\mathbb{e}}^{{- x}/B} - {\mathbb{e}}^{{- 12}/B}} \right)}}}\end{matrix}$

Find x for which A1₁₂ sec=A2

$\begin{matrix}{\frac{A\; 1}{12\mspace{14mu}\sec} = {{12 + B_{\mathbb{e}}^{{- 12}/B} - B} = {\frac{A2}{12 - x} = {x - 12 + {B\;{\mathbb{e}}^{{- x}/B}} - {B\;{\mathbb{e}}^{{- 12}/B}}}}}} \\{\left. \Rightarrow{24 + {2B\;{\mathbb{e}}^{{- 12}/B}} - B} \right. = {x + {B\;{\mathbb{e}}^{{- x}/B}}}}\end{matrix}$

One can then solve x for certain B's, creating a look up table whichdefines the range of possible time constants for a given catheter.

To implement the above, a device such as that schematically shown inFIG. 39 may be employed. In FIG. 39, sensor temperature T(t) is measuredby switch 780 when the pump is shut off (stop 768). In FIG. 39, asampling interval of 0.1 seconds is shown, but this can vary.

The calculation of A1/A2 proceeds next (step 770), followed by thedetermination of B from the look-up table (step 772). A is thencalculated (step 774), and from this ΔT, i.e., the correction factor(step 776). The projected temperature T(∞) may then be determined (step778). The various quantities discussed are shown in FIG. 40.

In more detail, and referring to FIG. 41, a state diagram is shown foran embodiment of the present invention. Steps according to the statediagram include: turning the system power on (step 730) and performingdesired data entry. This data entry (step 732) may include entering suchinformation as catheter size, target temperature, rate or period ofcooling or warming, and so on. Then the catheter and its accompanyingcirculation set may be connected to each other and to the console. Thesystem may then be purged (step 734). Following this, the system is inthe ‘stop’ mode (step 736), and the catheter may be inspectcd, inserted,etc. If desired, the system may enter a patient temperature mode inwhich the catheter-mounted thermistor may be employed to determine acontrol temperature (step 738). In this case, a delay of some ‘X’seconds is caused to occur (step 740), followed by temperaturemeasurement and averaging) (step 744) over Y seconds. Depending oncatheter size, X can range from zero seconds to, e.g., 24 seconds ormore. Following X, during Y, various temperatures can be measured, orotherwise determined, including T_(the) (t), T (t)_(CONTROL), and T(t)_(MONITOR). These may be acquired at, e.g., 10 Hz or such otherfrequency as may be desired. The average trend, with respect to time, ofthe temperature of the patient may be approximated by the average trendof the temperature of the HTE, i.e.,T _(p) (t)≅T _(HTE)(t)

The patient temperature may then be displayed, e.g., for 2 seconds (step746). The run mode may then be entered (step 742), and the patientcooled or warmed. The servo error may then be determined (step 744).Once the size of the servo error is determined, the interval, over whichit is safe to run in maximum cooling or heating mode, may then bedetermined (step 748). After this interval, the system pump is stoppedand a projection mode of the control temperature (step 782) is entered.The time the system is stopped may be, e.g., 10 seconds to 45 seconds,such as 15 seconds or 30 seconds. The projected temperature may then bethe basis for future calculations and, if desired, may be displayed.

As an example, during the induction phase of hypothermia, the pump isstopped approximately 3 to 5 times for about 15 to 30 seconds each, foreach new patient temperature estimate. So the total cool down times arelengthened a few minutes over an average cool down time.

FIG. 42 shows a comparator switch which may be employed in an embodimentof the invention. In FIG. 86, the closing of switch 788 initiates theintegration of area A1 by integrator 784, and the closing of switch 790initiates the integration of area A2 by integrator 786.

A different theoretical model is now employed to explain methods of theembodiment of the present invention. To model the transient behavior ofthe catheter immediately following the cessation of internal fluid flux,consider the simplified (axisymmetric) system of a circular cylinderwith temperature T₀ immersed in a steady axial fluid flow with constanttemperature T_(c) far from the cylinder. If the temperature on theinterior of the cylinder varies with time but is uniform at eachlongitudinal section, then, assuming that the longitudinal variation oftemperature within the cylinder is small compared to the difference intemperature between the cylinder and its environment, the time rate ofchange of temperature at each section of the cylinder is given by

$\begin{matrix}{\frac{\partial T}{\partial t} = {\alpha\left( {T_{c} - T} \right)}} & {{eq}.\mspace{14mu} 1}\end{matrix}$

where α is a constant which depends on the material properties of boththe cylinder and the exterior fluid in addition to the kinematics of theexternal flow field. This simplified analysis suggests that thetransient signal from a catheter-mounted temperature sensor willcorrelate with a function of the formT(t)=T _(∞) −C exp(−αt)  eq. 2where T_(∞) is the equilibrium temperature, C is the offset of T_(∞)from the starting temperature (which is necessarily unknown in the caseof data with non-negligible noise), and α depends on the materialproperties of the catheter and heat transfer fluid in addition to thematerial properties and kinematics of the exterior environment. If therange of α can be empirically bounded, then a simple procedureconsisting of a sequence of 2-dimensional least squares fits to afunction with the form of eq.2 is sufficient to determine T. whenever anupdated control signal is required.

To determine T_(∞) fluid flux in the catheter is first halted. After ashort period to allow dissipation of transient fluid motion, such as 15seconds, a sequence of n temperature values T_(i) from an embeddedthermistor are acquired at the rate 1/Δt, where Δt is the (constant)time interval between adjacent samples. For example, 30 samples may betaken at 2 second intervals. In order to avoid the non-linear systemresulting from direct application of the method of least squares to thedata T_(i) and a function with the form of eq.2, α is instead specifiedand the resulting 2-D linear system is solved. Assuming that in-vitroevaluation of catheter performance allows the statement that:α_(min)<α<α_(max)  eq. 3

for a specific catheter size, then the error between the temperaturedata and a function with the form of eq.2 is defined for a particular αas

$\begin{matrix}{{ɛ\left( \alpha_{j} \right)} = {\sum\limits_{i = 1}^{n}\;\left( {T_{i} - \left( {T_{\infty,j} - {C_{j}{\exp\left( {{- \alpha_{j}}t_{i}} \right)}}} \right)} \right)^{2}}} & {{eq}.\mspace{14mu} 4}\end{matrix}$

where α_(min)<α_(j)<α_(max). In practice, ε(α) is minimized with respectto T_(∞) and C for a sequence of α_(j) over the domain specified in eq.3with

$\begin{matrix}{{\alpha_{j} = {{\left( {j - 1} \right)\frac{\left( {\alpha_{\max} - \alpha_{\min}} \right)}{m - 1}} + \alpha_{\min}}};{1 \leq j \leq m}} & {{eq}.\mspace{14mu} 5}\end{matrix}$

If the resulting discrete representation of the function {circumflexover (ε)}(α) (where {circumflex over (ε)} represents the minimum valueof ε for a particular α) has a unique minimum in the domain specified ineq.3, then the triplet (T_(∞),C,α) which produces the best fit of thedata T_(i) with the assumed functional form is defined by the value of αassociated with the minimum in {circumflex over (ε)}(α). The number ofsamples m is chosen to provide sufficient resolution of the resultingfunction {circumflex over (ε)}(α).

For each α_(j), the corresponding T_(∞,j) and C_(j) which result in theminimum error {circumflex over (ε)}(α_(j)) are found by requiring thatthe two partial derivatives

$\begin{matrix}\begin{matrix}{\frac{\partial ɛ}{\partial T_{\infty}} = {- {\sum\limits_{i = 1}^{n}\;{2\left( {T_{i} - \left( {T_{\infty} - {C\;{\exp\left( {{- \alpha}\; t_{i}} \right)}}} \right)} \right)}}}} \\{\frac{\partial ɛ}{\partial C} = {\sum\limits_{i = 1}^{n}\;{2\left( {T_{i} - \left( {T_{\infty} - {C\;{\exp\left( {{- \alpha}\; t_{i}} \right)}}} \right)} \right){\exp\left( {{- \alpha}\; t_{i}} \right)}}}}\end{matrix} & {{eq}.\mspace{14mu} 6}\end{matrix}$

must vanish. Expressing eq.6 in matrix form,

$\begin{matrix}{{\begin{bmatrix}a_{11} & a_{12} \\a_{21} & a_{22}\end{bmatrix}\begin{bmatrix}T_{\infty} \\C\end{bmatrix}} = \begin{bmatrix}{RHS}_{1} \\{RHS}_{2}\end{bmatrix}} & {{eq}.\mspace{14mu} 7} \\{where} & \; \\\begin{matrix}{a_{11} = {\sum\limits_{i = 1}^{n}\;(1)}} & {a_{12} = {- {\sum\limits_{i = 1}^{n}\;{\exp\left( {{- \alpha}\; t_{i}} \right)}}}} \\{a_{12} = {\sum\limits_{i = 1}^{n}\;{\exp\left( {{- \alpha}\; t_{i}} \right)}}} & {a_{22} = {- {\sum\limits_{i = 1}^{n}\;{\exp\left( {{- 2}\alpha\; t_{i}} \right)}}}}\end{matrix} & {{eq}.\mspace{14mu} 8} \\{and} & \; \\{{RHS}_{1} = {\sum\limits_{i = 1}^{n}T_{i}}} & {{eq}.\mspace{14mu} 9} \\{{RHS}_{2} = {\sum\limits_{i = 1}^{n}{T_{i}{\exp\left( {{- \alpha}\; t_{i}} \right)}}}} & \;\end{matrix}$

Solving for T_(∞) and C, we find

$\begin{matrix}\begin{matrix}{T_{\infty} = \frac{{{RHS}_{1}a_{22}} - {{RHS}_{2}a_{12}}}{{a_{11}a_{22}} - {a_{21}a_{12}}}} \\{C = \frac{{{RHS}_{2}a_{11}} - {{RHS}_{1}a_{21}}}{{a_{11}a_{22}} - {a_{21}a_{12}}}}\end{matrix} & {{eq}.\mspace{14mu} 10}\end{matrix}$

Once T_(∞) and C are known, {circumflex over (ε)}(α_(j)) is computedwith eq.4. Finally, α (and the corresponding T_(∞) and C) which producesthe smallest least-squares error between the temperature data and afunction with the form of eq.2 is defined by the minimum of the discreterepresentation of the function {circumflex over (ε)}(α).

If the function {circumflex over (ε)}(α) has no unique minimum, or ifthe minimum in {circumflex over (ε)}(α) is greater than a specifiedlimit, the results of the procedure outlined above are ignored and theequilibrium temperature T_(∞) may be found by allowing the temperatureof the embedded temperature sensor to equilibrate with its externalenvironment.

Failure of the system identification algorithm may indicate improperplacement of the catheter (e.g., if the optimal α is smaller thanα_(min), the catheter may not have adequate external blood flux,indicating placement in a branching vein instead of the IVC).

Alternately, if α cannot reasonably be assumed constant over theduration of each therapy, then each instance of control signalacquisition, including the first instance following submission of the“run” command, must be treated as a system identification in which α isdetermined in addition to T. and C. Then a is assumed to be bounded asin the above. Then, with a specified interval Δα, T_(∞) and C arecomputed to minimize, in the least squares sense,

$\begin{matrix}{{ɛ_{j}\left( \alpha_{j} \right)} = {\sum\limits_{i = 1}^{n}\;\left( {T_{i} - \left( {T_{\infty\; j} - {C_{j}{\exp\left( {{- \alpha_{j}}t_{i}} \right)}}} \right)} \right)^{2}}} & {{eq}.\mspace{14mu} 11}\end{matrix}$

for each α_(j) in the domain. ε(α) then defines a function which, if thelimits were chosen correctly, obtains a minimum within the domain. Thisminimum in turn defines the time constant α and subsequently T_(∞) and Ccorresponding to the best fit, in the least squares sense, function ofthe form represented with the samples of temperature relaxation data.The minimum of ε(α) may be obtained by a simple sorting algorithm if thefunction 6 is computed with a relatively small εα. Alternatively, for amore sparse sampling of the function ε(α), a quadratic form may beassumed and the minimum found analytically. This alternative approachmay execute faster due to the relative cost of the quadratic curve fitas opposed to additional evaluations of equation 11.

Addition of 1^(st) Order Linear Term:

The basic exponential model outlined above is based on the assumptionthat the temperature of the external environment (i.e. blood in the IVC)is constant over the interval during which the embedded thermistor isallowed to equilibrate with that environment. In general, thetemperature of the external environment may be not constant over thisinterval.

While the catheter is in operation (e.g. in the cooling mode), thevarious compartments of the body, distinguished on the basis of bloodflux per unit mass, or specific blood flux, are in a dynamic state inwhich the heat removed by the catheter comes preferentially from thosetissues for which the specific blood flux is greatest. When coolant fluxin the catheter is halted, these physiologic compartments will tend toequilibrate. Tissues with the highest specific blood flux will warmrelative to those with lower specific flux as internal body heat isredistributed. As the redistribution of heat occurs primarily throughconvective transport by blood, the temperature of the environment of thecatheter must change as the physiologic compartments approachequilibrium.

While the blood temperature in the vicinity of the catheter generallyvaries over the interval during which the catheter equilibrates with itsenvironment, the functional form of that variation is not known. Forsimplicity, any time scale inherent in physiologic temperature variationmay be assumed to be greater than the time scale associated withrelaxation of temperature within the catheter and thus the physiologictemperature variation may be described with a Taylor series,

$\begin{matrix}{{T_{ext}(t)} = \left. {{T_{ext}\left( {t = 0} \right)} + \frac{\partial T_{ext}}{\partial t}} \middle| {}_{t = 0}{{{\cdot \Delta}\; t} + {O\left( {\Delta\; t^{2}} \right)}} \right.} & {{eq}.\mspace{14mu} 12}\end{matrix}$

where T_(ext) is the temperature of the environment and t=0 defines theinstant when heat flux through the catheter is halted. With the aboveassumption, Δt, which is the time during which temperature data isacquired from the embedded thermistor, is ‘small’ relative to the timeover which significant physiologic temperature changes will occur. Inthis situation, the variation of external temperature is accuratelymodeled by a simple linear function. With this understanding, it is notunreasonable to append the functional form of eq.2 with a linearcomponent to model the changing temperature of the external environmentT(t)=T _(∞) −Cexp(−αt)+βt  eq. 13

where β is the unknown rate of change of external temperature whichoccurs in the body after cessation of heat transfer through thecatheter.

The process for computation of the best fit function with the form ofeq.13 to the temperature data acquired from the embedded thermistor isanalogous to that described for the simpler 3-dimensional model. Aseries of values are assumed for α, and the resulting linear leastsquares problem for the error between the empirical data and the assumedfunctional form are solved for the triplet (T_(∞), C, β). The solutionis defined as the value of α and the associated (T_(∞), C, β) for whichthe least squares error is minimum.

Alternatively, one may assume another form for T_(ext)(t):T _(ext)(t)=T _(ext) ^(∞)−(T _(ext) ^(∞) −T _(ext) ⁰)exp(−βt)  eq. 14in which T_(ext), T_(ext) ^(∞), and T_(ext) ⁰, are, respectively, bloodtemperature in the environment of the catheter, the relaxed temperatureof the blood in the environment of the catheter and the correspondingtemperature at cessation of catheter flux. The constant β is thecharacteristic relaxation rate of blood temperature. Substituting bloodtemperature given in equation 14 for T_(c) in equation 1,

$\begin{matrix}{\frac{\mathbb{d}T}{\mathbb{d}t} = {\alpha\left\{ {T_{ext}^{\infty} - {\left( {T_{ext}^{\infty} - T_{ext}^{0}} \right){\exp\left( {{- \beta}\; t} \right)}} - T} \right\}}} & {{eq}.\mspace{14mu} 15}\end{matrix}$

The temperature measured by the sensor embedded in the catheter is thengiven by

$\begin{matrix}\begin{matrix}{{T(t)} = {T_{ext}^{\infty} - {\frac{\alpha}{\alpha - \beta}\left( {T_{ext}^{\infty} - T_{ext}^{0}} \right){\exp\left( {{- \beta}\; t} \right)}} +}} \\{\left\{ {T_{0} - T_{ext}^{\infty} + {\frac{\alpha}{\alpha - \beta}\left( {T_{ext}^{\infty} - T_{ext}^{0}} \right)}} \right\}{\exp\left( {{- \alpha}\; t} \right)}}\end{matrix} & {{eq}.\mspace{14mu} 16}\end{matrix}$for α≈β. T₀ is the starting temperature in the catheter. The requirementthat α≈β is not overly restrictive in practice since the characteristicrelaxation rate of the catheter is generally much larger than thecorresponding physiologic rate.

Correlation of equation 16 with a sequence of discrete temperature datasamples requires the solution of a 5-dimensional non-linear leastsquares problem. The solution set (T₀,T_(ext) ^(∞),T_(ext) ⁰,α,β) isobtained by assumingα_(min)<α<α_(max)β_(min)<β<β_(max)  eq. 17and solving for the remaining constants (T₀,T_(ext) ^(∞),T_(ext) ⁰) viaa sequence of (n×m) 3-dimensional linear least squares proceduressimilar to that described above, where n and m are, respectively, thenumber of discrete α and β values in the domains described by equation17. The best fit function with the form of equation 15 is chosen bysearching the resulting set of (n×m) 3-dimensional linear least squaressolutions for the combination of α and β which result in the smallestfit error.

In practice, insufficient computational resources are often availablefor real-time correlation of the functional form given in equation 14with patient temperature data. Instead, predictions are made using thesimpler 3-dimensional technique described above, and the more involved5-dimensional solution is employed for analysis of recorded data.Comparison of solutions obtained through the 3 and 5-dimensional curvefitting procedures suggests that α is roughly 25% greater than thatcomputed with the 3-dimensional procedure. This is not unexpected sincevariation of external temperature during catheter relaxation may beincluded in the computation of α with the simpler 3-dimensionalprocedure.

4 Application to AMI Patient Temperature Data:

Although the preferred result of the correlations described in sections2 and 3 is the computation of core body temperature, application of thealgorithm also produces the characteristic relaxation rate α exhibitedby the catheter temperature data during equilibration with theenvironment. This rate is useful for determining the degree to whichcatheter temperature has relaxed during a finite acquisition cycle.Expressing equation 2 in the form

$\begin{matrix}{{\ln\left( \frac{\Delta\;{T(t)}}{\Delta\; T_{0}} \right)} = {{- \alpha}\; t}} & {{eq}.\mspace{14mu} 18} \\{where} & \; \\{{\Delta\;{T(t)}} = {{T(t)} - T_{\infty}}} & {{eq}.\mspace{14mu} 19} \\{{\Delta\; T_{0}} = {T_{0} - T_{\infty}}} & \;\end{matrix}$the ratio of temperature differences can be seen to be correlated withthe degree of relaxation exhibited by the catheter temperature data in acertain time interval. In practice, temperature at the site of theembedded sensor during operation is roughly 10 C., so that relaxation tobody temperatures of the order of 35 C. results in an initial offsetfrom equilibrium of ˜25 C. Requiring the catheter temperature to relaxto within 0.5 C. of the equilibrium value in order for cathetertemperature to accurately reflect body temperature, it is seen thatαt=3.91  eq. 20The minimum value α must attain in order to satisfy the requirement thatcatheter temperature is relaxed to within 0.5 C. in a specified amountof time may now be determined. When t=90 sec., α_(min.)=0.043. Inanother example, for a less than 1% variation, then αt=4.6 timeconstants. And for α=0.06, then about half the data falls into therange, i.e., passes successfully through the projection “window”. In anycase, a larger number of samples assists the issue of averaging.

Higher Order Variations of Physiologic Temperature

It should be clear to practitioners skilled in the art, given theteaching above, that the method described above for the assumedfunctional forms may be extended to a variety of additional forms withboth linear and non-linear improvements to the basic exponential model.

Flux Drift As Spatial Integrator

As before, the working fluid flux would be halted during the time that acontrol temperature is obtained. With the heat transfer fluid fluxhalted, the heat path to the temperature sensor in either configurationis only conductive, through the plastic catheter shaft and the staticheat transfer fluid. The heat flux which causes the temperature sensorto relax to the temperature of its environment therefore necessarilyoriginates preferentially in the immediate vicinity of the temperaturesensor. If, in some configurations, heat flux into the catheter isreduced in this vicinity, the necessary relaxation time increases andprediction or measurement of the temperature will require longersampling intervals. Such a configuration may obtain when an introducercovers the temperature sensor, and in this case an additional thermalresistance would be imposed between the temperature sensor and theenvironment.

To obviate this difficulty, instead of halting the heat transfer fluid(working fluid) flux during temperature acquisition, the flux may bereduced to a creeping flow so that heat conducted through the entiremetallic shell of the heat transfer tip is convected past thetemperature sensor. If the flux is sufficiently slow, fluid entering theheat transfer tip will equilibrate with blood temperature before passingthe temperature sensor. In this way, the entire metallic shell of theheat transfer tip is employed as a spatial integrator to minimize thedependence of the temperature sensor relaxation rate or temperature onthe properties of the immediate environment of the temperature sensor.

Other Considerations for Catheter-Mounted Temperature Sensors

Analysis of human clinical data has revealed the presence of (at least)two distinct time scales associated with the relaxation of cathetertemperature in the above system. One of these intrinsic time scales isrelated to the geometry of the catheter and the properties of itsenvironment (e.g., vessel diameter and blood flux) while the other timescale appears to reflect a physiologically imposed time related toequilibration of (body) thermal compartments after cessation ofendovascular heat transfer. Both time scales appear to be related tosimple exponential decay of the associated physical process (i.e., heatflux into the catheter, and heat transfer between body compartments),and the temperature history recorded by the embedded temperature sensormay be a convolution of the two processes. Ideally, the resultingtemperature history appears as a rapid decay to within approximately 1°C. of the final value, governed by the catheter-intrinsic time scale,followed by a more gradual relaxation governed by the physiologic timescale. If the two time scales are distinct, a local asymptotictemperature related to the catheter-intrinsic time scale can beextrapolated through a simple non-linear least squares fit to a finitesample of catheter temperature data. This results in an approximation ofthe temperature which would have been obtained in the catheterenvironment in the absence of the 2nd process, i.e. equilibration ofbody compartments, which tends to occurs on a much longer time scale. Ifthe two time scales are similar, as might result if the thermal mass ofthe catheter were much larger, or if the sensor were located in a regionof restricted blood flux, then de-convolution of the two time scalesbecomes difficult and extrapolation of a useful asymptotic temperaturesomewhat more problematic.

Far distal placement of the temperature sensor, relative to and apartfrom the heat exchanger, may be associated with certain disadvantages.Cold fluid inside the heat transfer element will influence thetemperature recorded by a distally located sensor by extracting heatfrom the external blood before it passes over the sensor. If the thermalmass of the heat transfer element is large as, for example, in the caseof a large diameter balloon, then the catheter intrinsic time scale willincrease and prediction of the asymptotic temperature becomes difficult.In addition, turbulence or mixing in the blood may result influctuations in the recorded temperature if the sensor is close to theheat transfer element. However, moving the sensor even furtherdownstream may result in undesirable proximity of the sensor to tissue,such as cardiac tissue.

Placement of the temperature sensor within the catheter shaft (housingthe heat transfer fluid supply and return lumens) may be desirable.However, this necessitates careful consideration of the dynamics offluid motion in the supply and return lumens. If the supply/returnlumens are symmetric, or the same size and/or shape, then introductionof the temperature sensor assembly into one of the lumens will increasethe associated pressure drop along that path. If the sensor is placed inthe return lumen, pressure in the balloon will increase, resulting in amechanically stiffer balloon. If the sensor is placed in the supplylumen, the flux of heat transfer fluid will decrease unless pumppressure is increased. If instead the supply and return lumens areasymmetric, placement of the sensor assembly in the larger return lumenmay result in a negligible effect on catheter pressure and flux.

Use of a YSI-400 thermistor as the temperature sensing device may bedesirable. This may render the device compatible with most of thedigital thermometers in the clinical environment. If fluid pathrestrictions, as described above, necessitate the use of a smallerthermocouple device, the associated electronics (i.e. accurate andexpensive millivolt amplifiers with temperature compensated junctions)become more complicated and incompatible with the popular clinicalequipment. Additionally, thermocouple accuracy is generally less thanthat available with a thermistor.

Temperature Estimation Errors & Accuracy:

The ability of the system to control to a desired set point or targettemperature may be limited by the cooling power, degree of thermaldisturbance (discussed below), accuracy of measuring the temperaturewithin the catheter, patient temperature drift during the samplingperiod when the pump is turned off, and the accuracy of the estimationalgorithm.

Clinical experience in neurosurgical settings has shown that the coolingpower required to maintain hypothermia at 33° C. is less than about 20%of the maximum power capability of the system even when a convectivewarming blanket is used during the hypothermia maintenance period. Witha servo gain of 0.2 C. for 100% power, a 20% load would yield a servoType 1 offset of 20%×0.2 C.=0.04 C. error. For a 9 fr catheter which hasabout 65% of the 14 fr capability, this would yield a offset errorduring hypothermia maintenance of approximately 30%×0.2 C.=0.06 C. Inthe setting of stroke and acute myocardial infarction, the steady stateload during maintenance is approximately the same; i.e., about 0.06 Coffset due to the need to continue to extract heat out of the patient tobalance the patient's retained metabolic heat due to surface warming.

The accuracy of the thermistor may have, e.g., a specification of +/−0.1C. for 100% confidence (4 standard deviations) in the temperature rangeof 32 to 42 C. The electronics and signal processing may have, e.g., aspecification of +/−0.1 C. (95% confidence =+/−2 S.D.) to cover theinitial calibration, dynamic temperature range, drift, and agingconsiderations. The calibration of the hardware temperature channels maybe checked and recalibrated if needed on, e.g., an annual basis. Theaccuracy of the thermistor and the hardware signal conditioning andprocessing is comparable to other commercially available temperaturemonitoring disposable sensors and equipment used routinely in thehospital operating room and intensive care settings for monitoringpatient temperature.

During the sample period of acquiring temperature sensor data,approximately 30 seconds for the 9 fr and 60 seconds for 14 fr device,the patient can rewarm due to retained metabolic heat and cessation ofheat extraction. In one clinical study, the maximum rate of rewarmingobserved was. less than about 1.5 C./hour or approximately 0.025 C. in60 seconds.

A last error source is the ability of the temperature estimationalgorithm to predict the final value of the sensor's temperatureresponse to a step input. An error sensitivity analysis was conducted byvarying the sampling time duration (acquisition period) and comparingthe estimated temperature to the actual temperature. For 20 seconds ofsample points (total of 24 seconds of the pump being in the “off” mode),the standard deviation of the error was 0.1 C. Decreasing the samplepoints to 15 (total 19 seconds of pump off) increases the standarddeviation of error to 0.18 C. while increasing the sample points to 25(total of 29 seconds) decreases the standard deviation to 0.7 C. A 20sample point algorithm has been chosen for an optimal trade off of timeversus estimation accuracy.

Thus the temperature measurement and estimation accuracy has variouscomponents, which can be considered statistically independent errorsources (See Table VIII). Summing these error sources would yield themaximum expected error, 95% confidence, of, e.g., about 0.51 C. Takingthe root mean square error, i.e., RMS error, would be about 0.26 C.

Potential Thermal Disturbances:

One design goal of a closed loop servo controller is to have sufficientcapability to maintain control during various load conditions. Thiscapability in embodiments of the present invention is expressed as themaximum thermal power available to null out a disturbance, at whatamount of energy is it delivered for a particular servo error magnitude,defined as the servo gain, and the responsiveness of the controller thatmay have intentional lags or leads in the feedback controller forcontrol stability. Since the patient's response to a thermal input istypically slow, over hours, no additional magnitude or phasecompensation may be required in the controller to optimize stability.The key ingredient to loop stability is the servo gain level, which hasbeen chosen to be in the range of 500 to 800 watts per degree C. oferror depending on which catheter size is chosen. With this servo gainlevel, clinical studies have demonstrated few or no instability problemswith minimal steady state servo error and good response.

A potential thermal disturbance would be an IV infusion of roomtemperature (cold) fluids. For a constant infusion rate of 1.4 ml/min (2liters per 24 hours) of 20° C. fluid, this would represent a thermalinput rate of about 2 watts. The system would have to develop a servoerror of approximately (2 watts)/(600 watts/C.) or 0.003 C. to correctfor this steady state thermal disturbance. Since 2 watts is well withinthe capability of embodiments of the present invention, this disturbancewould be well controlled.

A more challenging thermal disturbance would be a rapid bolus infusionof fluids, such as 250 ml, in, e.g., 5 minutes. If the fluid were notheated to body temperature, this would represent an infusion rate ofabout 1 cc/sec at 20 C. for an equivalent energy input of about 70 wattsfor 5 minutes. It takes about 70 to 85 watts for one hour to lower thebody temperature of an average patient, 70 kg weight, one degree C.Thus, a 5 minute bolus would have the effect of lowering the temperature5/60th of one degree, 0.083 C., again well within the capabilities ofthe present system to control.

In actual clinical deployment of embodiments of the present invention, aconvective or electrical heating blanket may be used for patient comfortand for depressing shivering. The blanket temperature setting and howmuch of the patient's body is exposed to the blanket will determine thenet transfer of energy from the patient to the room. Sessler et. al.estimate that a typical blanket can prevent 20 to 50 watts of heat lossto the environment. A 50 watt heat preservation would require theembodied system to extract an additional 50 watts of cooling to maintainthe thermal balance. The servo error would move to 50 Watts/600watts/C.=0.083 C., again well within the capability of the system.

In summary, most if not all of the thermal disturbances as describedabove are within the capability of embodiments of the closed loopcontrol system to maintain the target temperature within 0.5 C.

As previously mentioned, control algorithms are sometimes used tocontrol the rate at which heat is extracted from the body by thecatheter. These algorithms may be embodied in hardware, software, or acombination of both. The gain factor employed by such algorithms isdependent on the effective thermal mass of the body or organ beingcooled. Thus, it is important to determine the effective thermal mass sothat an appropriate gain factor can be calculated for the feedbackcontrol algorithm.

The mass of the body (organ or whole body) being cooled can be estimatedby relating the power removed by the catheter to the power lost by thebody.

The power removed by the catheter may be expressed as follows:P_(catheter=Mc) _(f)ΔT  (1)

Where M is the mass flow rate of the fluid circulating through thecatheter (typically measured in terms of cc/s), c_(f) is the heatcapacity of the fluid, and ΔT is the temperature difference between theworking fluid as it enters the catheter and as it exits the catheter.Accordingly, P_(catheter) can be readily calculated by measuring themass flow of the circulating fluid and the temperature differencebetween the working fluid as it enters and exits the catheter.

The power removed by the catheter as determined by equation (1) may beequated to the power that is lost by the patient's body:P_(catheter=mc) _(b)∂T/∂t  (2)

Where P_(catheter) is now the power lost by the patient's body and hasthe value calculated by equation (1), m is the effective thermal mass ofthe body being cooled, c_(b) is the heat capacity of the body, and ∂T/∂tis the change in temperature per unit time of the mass being cooled.

Accordingly, the effective thermal mass of the body being cooled is:m=P _(catheter)/(c _(b) ∂T/∂t)  (3)

Since all the variables in equation (3) are either known or aremeasurable, the effective mass can be determined.

The mass calculated in this manner is an effective thermal mass thatrepresents the portion of the body from which power is removed (i.e.,the portion of the body that is cooled). The temperature change inequation (3) represents the temperature change of the portion of thebody being cooled. For example, if whole body cooling is to beperformed, the change of the core body temperature may be measured tocalculate mass in accordance with equation (3). In the effective massmay represent about 50% of the total body mass. If the patient isvasodilated, the effective mass will be closer to the total body mass.

Alternatively, if only a selected organ such as the brain is to becooled, then the temperature change that will be used in equation (3)would be the temperature change of the organ, assuming of course thatthe organ can be at least briefly considered to be largely thermallyisolated from the remainder of the body. In this case the effective massthat is determined would be comparable to the mass of the organ. If theselected organ to be cooled is the brain, for example, the catheter isplaced in the common carotid artery, the internal carotid artery, orboth. The temperature changed used in equation (3) will be measured byinserting a temperature sensor into the brain or via a tympanic membranesensor, both of which are commercially available.

EXAMPLE

In an animal study, whole body cooling was accomplished by inserting thecatheter through the femoral vein and then through the inferior venacava as far as the right atrium and the superior vena cava. Cooling wasinitiated by circulating a working fluid at a flow rate of 5 cc/sec. Thetemperature differential between the fluid entering the catheter and thefluid exiting the catheter was 17° C. Accordingly, the power extractedby the catheter was 354 watts.

The body core temperature was measured through the esophagus. Twentyminutes after cooling was initiated, the rate at which the coretemperature changed was measured over a period of about ten minutes,resulting in an average temperature change of about 4° C./hr.

From equation (3) above, the effective thermal mass is:m=354 watts/(0.965 watts/kg C.°)(10° C./hr)=37 kg

The total mass of the animal was 53 kg, and thus the effective mass wasfound to be 69% of the total mass. One practice of the present inventionis illustrated in the following non-limiting example.

Exemplary Procedure

1. The patient is initially assessed, resuscitated, and stabilized.

2. The procedure may be carried out in an angiography suite or surgicalsuite equipped with fluoroscopy.

3. An ultrasound or angiogram of the external jugular/superior vena cavaor femoral vein/inferior vena cava can be used to determine the vesseldiameter and the blood flow; a catheter with an appropriately sized heattransfer element can be selected.

5. After assessment of the veins, the patient is sterilely prepped andinfiltrated with lidocaine at a region where the femoral artery may beaccessed.

6. The, e.g., femoral vein is cannulated and a guide wire may beinserted to the inferior vena cava. Placement of the guide wire isconfirmed with fluoroscopy.

7. An angiographic catheter can be fed over the wire and contrast mediainjected into the vein to further to assess the anatomy if desired.

8. Alternatively, the femoral vein is cannulated and a 10-12.5 french(f) introducer sheath is placed.

9. A guide catheter may be placed into the inferior vena cava. If aguide catheter is placed, it can be used to deliver contrast mediadirectly to further assess anatomy.

10. The cooling catheter is placed into the inferior vena cava via theguiding catheter or over the guidewire.

11. Placement is confirmed if desired with fluoroscopy.

12. Alternatively, the cooling catheter shaft has sufficient pushabilityand torqueability to be placed in the inferior vena cava without the aidof a guide wire or guide catheter.

13. The cooling catheter is connected to a pump circuit also filled withsaline and free from air bubbles. The pump circuit has a heat exchangesection that is immersed into a water bath and tubing that is connectedto a peristaltic pump. The water bath is chilled to approximately 0° C.

14. Cooling is initiated by starting the pump mechanism. The salinewithin the cooling catheter is circulated at 5 cc/sec. The salinetravels through the heat exchanger in the chilled water bath and iscooled to approximately 1° C.

15. The saline subsequently enters the cooling catheter where it isdelivered to the heat transfer element. The saline is warmed toapproximately 5-7° C. as it travels along the inner lumen of thecatheter shaft to the end of the heat transfer element.

16. The saline then flows back through the heat transfer element incontact with the inner metallic surface. The saline is further warmed inthe heat transfer element to 12-15° C., and in the process, heat isabsorbed from the blood, cooling the blood to 3° C. to 35° C. Duringthis time, the patient may be warmed with an external heat source suchas a heating blanket. At any point in the procedure, thermoregulatorydrugs, such as anti-shivering drugs, may be administered.

17. The chilled blood then goes on to chill the body. It is estimatedthat less than an hour will be required to cool the brain to 30° C. to35° C.

18. The warmed saline travels back the outer lumen of the catheter shaftand is returned to the chilled water bath where the same is cooled to 1°C.

19. The pressure drops along the length of the circuit are estimated tobe between 1 and 10 atmospheres.

20. The cooling can be adjusted by increasing or decreasing the flowrate of the saline. Monitoring of the temperature drop of the salinealong the heat transfer element will allow the flow to be adjusted tomaintain the desired cooling effect.

21. The catheter is left in place to provide cooling for, e.g., 6-48hours.

It is envisioned that the following veins may be appropriate topercutaneously insert the heat transfer element: femoral, internaljugular, subclavian, and other veins of similar size and position. It isalso envisioned that the following veins may be appropriate in which todispose the heat transfer element during use: inferior vena cava,superior vena cava, femoral, internal jugular, and other veins ofsimilar size and position.

Methods of Use Employing Thermoregulatory Drugs

The above description discloses mechanical methods of rewarming apatient, or portions of a patient, to minimize the deleteriousconsequences of total body hypothermia. Another procedure which may beperformed, either contemporaneous with or in place of mechanicalwarming, is the administration of anti-vasoconstriction andanti-shivering drugs. Such drugs minimize the effect of vasoconstrictionwhich may otherwise hinder heat transfer and thus cooling of thepatient. In general, hypothermia tends to trigger aggressivethermoregulatory defenses in the human body. Such drugs also prohibitresponses such as shivering which may cause damage tocardiac-compromised patients by increasing their metabolic rate todangerous levels.

To limit the effectiveness of thermoregulatory defenses duringtherapeutic hypothermia, drugs that induce thermoregulatory tolerancemay be employed. A variety of these drugs have been discovered. Forexample, clonidine, meperidine, a combination of clonidine andmeperidine, propofol, magnesium, dexmedetomidine, and other such drugsmay be employed.

It is known that certain drugs inhibit thermoregulation roughly inproportion to their anesthetic properties. Thus, volatile anesthetics(isoflurane, desflurane, etc.), propofol, etc. are more effective atinhibiting thermoregulation than opioids which are in turn moreeffective than midazolam and the central alpha agonists. It is-believedthat the combination drug of clonidine and meperidine synergisticallyreduces vasoconstriction and shivering thresholds, synergisticallyreduces the gain and maximum intensity of vasoconstriction andshivering, and produces sufficient inhibition of thermoregulatoryactivity to permit central catheter-based cooling to 32° C. withoutexcessive hypotension, autonomic nervous system activation, or sedationand respiratory compromise.

These drugs may be particularly important given the rapid onset ofthermoregulatory defenses. For example, vasoconstriction may set in attemperatures of only ½ degree below normal body temperature. Shiveringsets in only a fraction of a degree below vasoconstriction.

The temperature to which the blood is lowered may be such thatthermoregulatory responses are not triggered. For example,thermoregulatory responses may be triggered at a temperature of 1-1½degrees below normal temperature. Thus, if normal body temperature is37° C., thermoregulatory responses may set in at 35° C. Thermoregulatorydrugs may be used to lower the temperature of the thermoregulatorytrigger threshold to 33° C. Use of the heating blankets described abovemay allow even further cooling of the patient. For example, to lower thepatient's temperature from 33° C. to 31° C., a 2° C. temperaturedifference, a 2 times 5° C. or 10° C. rise is surface temperature may beemployed on the skin of the patient to allow the patient to not “feel”the extra 2° C. cooling.

A method which combines the thermoregulatory drug methodology and theheating blanket methodology is described with respect to FIG. 43. Thisfigure is purely exemplary. Patients' normal body temperatures vary, asdo their thermoregulatory thresholds.

As shown in FIG. 43, the patient may start with a normal bodytemperature of 37° C. and a typical thermoregulatory threshold of 35° C.(step 432). In other words, at 35° C., the patient would begin to shiverand vasoconstrict. A thermoregulatory drug may be delivered (step 434)to suppress the thermoregulatory response, changing the thresholdtemperature to, e.g., 35° C. This new value is shown in step 436. Theheat transfer element may then be placed in a high flow vein, such asthe superior or inferior vena cavae or both (step 438). Cooling mayoccur to lower the temperature of the blood (step 440). The cooling maybe in a fashion described in more detail above. The cooling results inthe patient undergoing hypothermia and achieving a hypothermictemperature of, e.g., 33° C. (step 442). More cooling may be performedat this stage, but as the thermoregulatory threshold has only beensuppressed to 33° C. (step 442), shivering and vasoconstriction woulddeleteriously result. This may complete the procedure. Alternatively, anadditional drug therapy may be delivered to further lower thethermoregulatory threshold.

An alternate way to lower the thermoregulatory threshold is to use aheating blanket. As noted above, a common rule-of-thumb is that apatient's comfort will stay constant, even if their body temperature islowered 1° C., so long as a heating blanket, 5° C. warmer than theirskin, is applied to a substantial portion of the surface area of thepatient (step 444). For a 2° C.-body temperature reduction, a 10° C.(warmer than the skin temperature) blanket would be applied. Of course,it is also known that blankets warmer than about 42° C. can damagepatient's skins, this then being an upper limit to the blankettemperature. The patient's body temperature may then continue to belowered by use of a heating blanket. For each 1° C. reduction in bodytemperature (step 446), the heating blanket temperature may be raised 5°C. (step 448). After each reduction in body temperature, the physicianmay decide whether or not to continue the cooling process (step 450).After cooling, other procedures may be performed if-desired (step 452)and the patient may then be rewarmed (step 454).

It is important to note that the two alternate methods ofthermoregulatory response reduction may be performed independently. Inother words, either thermoregulatory drugs or heating blankets may beperformed without the use of the other. The flowchart given in FIG. 43may be used by omitting either step 434 or steps 444 and 448.

Vasoconstrictive Therapies

High blood flow organs have a more rapid response to hypothermia thanthat of the peripheral circulation. This response may be maintained orenhanced by applying, as an alternative method of performinghypothermia, a cooling blanket rather than a heating blanket. Thecooling blanket may serve to vasoconstrict the vessels in the peripheralcirculation, further directing blood flow towards the heart and brain.

An alternate method of performing the same function is to provideseparate vasoconstrictive drugs which affect the posterior hypothalamusin such a way as to vasoconstrict the peripheral circulation whileallowing heart and brain circulation to proceed unimpeded. Such drugsare known and include alpha receptor type drugs. These drugs, as well asthe cooling blankets described above, may also enhance counter-currentexchange, again forcing cooling towards the heart and brain. Generally,any drug or cooling blanket that provides sufficient cooling to initiatea large scale cutaneous peripheral vasoconstrictive response would becapable of forcing the cooling blood flow towards the brain and heart(i.e., the “central” volumes). In this application, the term “peripheralcirculation” or “peripheral vasculature” refers to that portion of thevasculature serving the legs, arms, muscles, and skin.

Antishiver Drugs and Regimens

Other thermoregulatory drugs are now described. Meperidine is ananalgesic of the phenyl piperdine class that is known to bind to theopiate receptor. Meperidine is also used to treat shivering due topost-operative anesthesia and hypothermia. Meperidine can also treatrigors associated with the administration of amphotericin B.

Meperidine can also be used to control shivering when hypothermia isinduced clinically. During periods of ischemia, such as occurs during astroke or heart attack, hypothermia can protect the tissue from damage.It is important to be able to cool patients with out inducing a generalanesthetic condition requiring intubation. To cool conscious patientsrequires very high doses of meperidine. Cooling of patients can beaccomplished by the above noted methods such as cooling blankets (air orwater) or alcohol bathing. Cooling can also be accomplished by bodycavity lavage (bladder, stomach, colon, peritoneal). The most efficientway to cool patients, as noted above for therapeutic purposes, is usingan intravascular catheter. An intravascular cooling catheter has a heatexchange region that is responsible for exchanging heat with the blood.Absorption of heat from the blood by the heat exchange region results incooling of the body. Causing mixing, or turbulence, on, or near, theheat exchange region, enhances heat transfer by intravascular methods.The heat exchanger of the intravascular catheter can have features thatinduce turbulence or mixing.

Shivering is regulated by the hypothalamus of the brain. Thehypothalamus regulates body temperature in general by controlling heatproduction and heat loss. Heat production above the base metabolic levelis produced through shivering, while heat loss is prevented byvasoconstriction, which decreases blood flow to the skin/periphery. Thenormothermic set point of the hypothalamus is approximately 37° C. Whenthe body is cooled a threshold is reached at which vasoconstriction andshivering occur. Vasoconstriction occurs approximately 0.5-1.0° C. belowthe set point, with shivering occurring 1.0-1.5° C. below the set point.The intensity of shivering increases proportionally with the differencefrom the threshold up to a maximum intensity. Meperidine lowers thethreshold at which shivering occurs, but it does not have much effect onthe gain and maximum intensity. The reduction of the shivering thresholdis proportional to the serum concentration of meperidine, such thatgreater serum concentrations cause a greater reduction in the threshold.Meperidine is believed to possess special antishivering effects, inparticular because it decreases the shivering threshold twice as much asthe vasoconstriction threshold. In addition, it prevents or managesshivering better than equianalgesic doses of other opioids.

Meperidine's antishivering effects (lowering of the shivering,threshold) may not be related to binding of the opiate receptor.Meperidine is known to have numerous non-opioid effects such asanticholinergic action and local anesthetic properties. Further, theantishivering effects produced by meperidine are not antagonized bynalaxone, an opiate receptor antagonist. In addition, other opiates suchas morphine, pentazocine, and nalbuphine have lesser or no antishiveringactivity.

Meperidine usage has a number of undesirable side effects, and many arerelated to the affinity for the opiate receptor. The most serious isrespiratory sedation, which can result in death, and may be related toaffinity for the delta opiate receptor. It has been shown that blockingthe delta opiate receptor with an antagonist can reduce or eliminateopioid induced respiratory sedation. In addition, meperidine ismetabolized in the liver by n-demethylation, which produces themetabolite nor-meperidine. Nor-meperidine is known to have centralnervous system toxicity and can cause seizures. Meperidine cannot beused in patients with renal insufficiency or kidney failure due to arapid build up of the normeperidine metabolite. In addition, meperidinecannot be used in patients taking monoamine oxidase inhibitors, due tocomplications such as convulsions and hyperpyrexia.

Prodines (alpha and beta) are structurally very similar to meperidine.They too bind to the opiate receptor, though with greater affinity.Unlike meperidine, prodines have chirality. Chiral molecules have atleast one asymmetric atomic center that causes the mirror image of thebase molecule to be non-superimposable on base molecule. Each species,the base molecule and the mirror image, is referred to as an enantiomer.

Chiral molecules are optically active meaning each enatiomer can rotatea plane of polarized light equal but opposite directions, clockwise andcounter clockwise, plus and minus. Thus if one enantiomer rotates aplane of polarized light +10 degrees {(+) enantiomer}, the oppositeenantiomer will rotate light −10 degrees {(−) enantiomer)}. For example,the two prodines, known as alpha and beta, differ in the position of the3-methyl group. A chiral atomic center exists at the carbon to which the3-methyl group is bound and results in the various enantiomeric species.The chemical reactions that produce chiral molecules often produceracemic mixtures, or mixtures that contain fractions of each enantiomer.A racemic mixture that contains equal proportions of each enatiomer isoptically inactive.

Binding to the opiate receptor is known to be stereoselective. Thismeans that one enantiomer has much greater affinity for the receptorthan the other enantiomer. For example, the (−) isomer of morphine hasmuch greater affinity for the opiate receptor than the (+) isomer. Inthe case of alpha and beta prodine, the (+) isomer has much greateraffinity for the receptor than the (−) isomer.

It is reasonable to assume that the prodines have anti-shiver effectssimilar to meperidine due to their structural similarity. This is areasonable assumption because fentanyl, an opioid analgesic that is alsostructurally related to meperidine, also has anti-shiver effects.Fentanyl, also has opiate related side effects such as respiratorysedation.

The ideal antishiver medication or regimen would have potent antishiverefficacy with little respiratory sedation or other side effects. One wayto accomplish is to use meperidine, fentanyl, or other opioids withantishiver effects, in combination with a delta opiate receptorantagonist. Naltrindole or naltriben are competitive antagonists at thedelta receptor and can block the respiratory sedation caused byfentanyl. Thus, inducing hypothermia in a conscious patient using anintravascular cooling catheter would be accomplished using a drugregimen that included an opiate such as fentanyl or meperidine incombination with a delta receptor antagonist, such as naltrindole.

A molecule structurally similar to meperidine, but unable to bind to theopiate receptor or having antagonism at the opiate receptor, wouldlikely possess anti-shiver effects, but not opiate related respiratorysedation, since anti-shivering effects may be mediated through adifferent receptor. This ideal anti-shiver molecule exists in the formof the (−) isomer of alpha or beta prodine. The ratio of opiate efficacy(+/−) between the enantiomeric forms of alpha and beta prodine is atleast ˜10 to 30 fold. Because of the structural similarity to meperidinethey would likely retain the antishiver efficacy. In an analogousexample, dextromethorphan is a morphine-based chemical that is a coughsuppressant (antitussive). Dextromethorphan, which is the (+) methoxyenantiomer of (−) levorphanol, has retained the antitussive effects ofmorphine derivatives (i.e. (−) levorphanol), but lost other opiateeffects such as analgesia, respiratory sedation, and addiction. Inaddition, the opiate receptor affinity of the (+) isomer of alpha andbeta prodine could also be interrupted. This can be accomplished byadding a hydroxyl (particularly in the m position) to phenyl ring. Thisis particularly true of the potent opiate analgesic alpha-allylprodine,in which the 3-methyl is replaced with an allyl group. Further, theopiate activity of (+) betaprodine isomer can be significantlydiminished by the substitution of the 3-methyl group with an n-propyl orallyl group. These modifications to the (+) isomers of the prodinemolecules that inhibit opiate activity will not likely effect antishiveractivity due to the structural similarity to meperidine.

Cis-Picenadol, 1,3 dimethyl-4-propyl-4-hydroxyphenyl piperdine (cis3-methyl, 4-propyl) is phenyl piperdine compound in which the (−)enantiomer has antagonist properties at the opiate receptor. Due to thestructural similarity to meperidine, this (−) enantiomer may haveanti-shiver activity with little respiratory sedation. It is known thatthe racemic mixture of this opioid has a ceiling effect with respect torespiratory sedation when used in animals. This ceiling effect may makeracemic picenadol a better anti-shiver drug than meperidine. Finally,tramadol may have an enantiomer that has reduced opiate activity thatcould lower the shiver threshold.

Alpha prodine has been used as an analgesic in clinical medicine,marketed under the trade name Nisentil. The drug is supplied as aracemic mixture. It is possible to separate the racemic mixture into twopure isomers and use the (−) isomer as an antishiver medication. Such aseparation can be accomplished using high-performance liquidchromatography (HPLC) using a chiral stationary phase. One such chiralstationary phase is cellulose-based and is supplied as Chiralcel OD andChiralcel OJ.

A representative example of the use of the novel antishiver, orthreshold lowering, drugs or regimen, is a clinical procedure to inducehypothermia in a patient. The patient would first be diagnosed with anischemic injury, such as a stroke or heart attack. An intravascularcooling catheter or a cooling blanket would be applied to the patient.The patient would be given an intravenous injection of the novel antishiver drug, such as (−) alpha prodine. Alternatively the patient couldbe given meperidine or fentanyl in combination with a delta opiatereceptor antagonist. Buspirone could be given in combination with eitherof the above regimens because it is know to enhance the antishivereffects of meperidine. The patient would be cooled to 32-35° C. orlower. During the maintenance of cooling which could last 12-48 hours orlonger, doses of the antishiver drug or regimen would begin to maintaina certain plasma concentration. An infusion of the novel antishiver drugcould be used to maintain the plasma concentration. When the cooling wascomplete the patient would be rewarmed and the drugs discontinued.

Another ideal antishiver drug may be nefopam. Nefopam is widely used asan analgesic, particularly outside the U.S. While it is not an analog ofmeperidine, it has similar structural and conformational properties. Forexample it has a phenyl group attached to a N-methyl ring, and thephenyl group prefers the equatorial position. Similar to meperidine,nefopam is known to prevent post-operative shivering and to preventshivering related to Amphotericin B administration. However, nefopam hasless respiratory depression side effects, and is not metabolized into aneurotoxic compound. Injectable nefopam is a racemic mixture. Analgesicactivity resides in the (+) enantiomer. The (−) enantiomer may be aselective anti-shiver drug and superior to the racemic form. Combiningnefopam with intravascular catheter based cooling induction may allowfor successful implementation of therapeutic hypothermia.

It may also be desirable to use combinations of the compounds listedabove or combine them with other drugs that can reduce shivering andlower the threshold. This may lower the doses needed for either drug andreduce side effects. For example, one could combine nefopam with (−)alpha-prodine, meperidine, thorazine, buspirone, clonidine, tramadol, orother medications to achieve the desired effect. The same combinationscould be used with (−) alpha-prodine. There are many other combinationsthat could be tried including combining three agents together. Thesecombinations can be used with endovascular or surface hypothermiainduction for therapeutic purposes.

While the particular invention as herein shown and disclosed in detailis fully capable of obtaining the objects and providing the advantageshereinbefore stated, it is to be understood that this disclosure ismerely illustrative of the presently preferred embodiments of theinvention and that no limitations are intended other than as describedin the appended claims.

TABLE I Δ Patient Target-T_(Blood) 14 fr Sampling Duty Sampled IntervalCycle   4° C.  30 minutes 95%   3° C.  20 minutes 93%   2° C.  15minutes 90%   1° C.   7 minutes 82%  0.5° C.   3 minutes 66% 0.25° C.1.5 minutes 50% *Assuming 1.5 minute sampling time (pump off).

TABLE II Time Δ from (seconds) Temp. ° C. Steady State  0 ~18.2° C.19.2° C. 10 35.5  1.9° C. 20 36.7  0.7° C. 24 36.9  0.5° C. 26 37.0 0.4° C. 29 37.1  0.3° C. 35 37.2  0.2° C. 50 37.3  0.1° C. 90 37.4  0.0

TABLE III Max. Catheter Max Cooling Rewarm Rate Size Rate ObservedObserved 14 fr <8° C./Hr <4.0° C./Hr  9 fr <4° C./Hr <4.0° C./HrEstimated with an accelerated rewarm (50° C. Bath)

TABLE IV Current Temp. − Target Temp. 9 fr. 14 fr. 37° − 33° C. = 4° C. 60 minutes  30 minutes “cooling” 36° − 33° C. = 3° C.  45 minutes 22.5minutes  35° − 33° C. = 2° C.  30 minutes  15 minutes 34° − 33° C. = 1°C.  15 minutes 7.5 minutes 34.5° − 33° C. = 0.5° C. 7.5 minutes 3.7minutes 33° − 37° C. = 4° C.  60 minutes  60 minutes “warming” 34° − 37°C. = 3° C.  45 minutes  45 minutes 35° − 37° C. = 2° C.  30 minutes  30minutes 36° − 37° C. = 1° C.  15 minutes  15 minutes 36.5° − 37° C. =0.5° C. 7.5 minutes 7.5 minutes

TABLE V

TABLE VI Example Servo Error Example Pump/Power % >0.18° C. 100%  0.18°C. to 0.135° C.  75%  0.09° C. to 0.045° C.  50% 0.045° C. to 0.000° C. 25% 0.000° C.  0%

TABLE VII A1/A2 Ratio B 0.565  6 seconds 0.513  8 seconds 0.478 10seconds 0.455 12 seconds 0.439 14 seconds 0.426 16 seconds 0.415 18seconds

TABLE VIII Error Magnitude 2 Error Source S.D. Steady state error in0.06 C. maintenance (due to system power & gain capability) Temperaturesensor <0.10 C.   accuracy Hardware/signal 0.10 C. processing Estimationalgorithm 0.20 C. Patient rewarming 0.05 C. during sampling period

1. In a system in which a working fluid is circulated through a catheterand a heal transfer element, the working fluid having a temperaturedifferent from a patient temperature, a method of controlling theadministration of a thermal therapy, comprising: entering a targetpatient temperature into the system; inserting a catheter having a heattransfer element positioned at a distal tip of the catheter into a bloodvessel of a patient, the catheter having a supply lumen fin supplying aworking fluid to the heat transfer element and a return lumen forreturning a working fluid from the heat transfer element; circulating aworking fluid through the catheter and the heat transfer element, theworking fluid having a temperature different from the patienttemperature; circulating a working fluid and not determining a controltemperature, for a predetermined period of time based on the differencebetween a temperature determined from a signal from a temperature sensormounted at or adjacent the distal tip of the heat transfer element andthe target patient temperature; after the predetermined period of time,receiving a signal from the temperature sensor and determining a controltemperature based on the signal; using the control temperature tocontrol the temperature of the working fluid.
 2. The method of claim 1,further comprising causing the working fluid to stop circulating, andwherein the receiving includes: allowing a first interval of time topass; and collecting data from the temperature sensor during a secondinterval of time. such that the allowing and collecting each follow thecausing.
 3. The method of claim 2, wherein no data is collected duringthe first interval.
 4. The method of claim 3, wherein data is collectedduring the second interval at a predetermined frequency.
 5. The methodof claim 2, wherein the first interval is between about 5 and 15seconds.
 6. The method of claim 5, wherein the first interval is betweenabout 10 and 12 seconds.
 7. The method of claim 2, wherein the secondinterval is between about 10 and 30 seconds.
 8. The method claim 7,wherein the second interval is between about 15 and 25 seconds.
 9. Themethod of claim 2, wherein the first interval is about the same lengthof time as second interval.
 10. The method of claim 2, wherein the firstand second intervals are different lengths of time.
 11. The method ofclaim 2, further comprising integrating a value of the signal over thefirst interval with respect to time to derive a first area.
 12. Themethod of claim 11, further comprising integrating a value of the signalover the second interval with respect to time to derive a second area.13. The method of claim 12, further comprising dividing the first areaby the second area to calculate a value that is a function of a timeconstant of an exponential function.
 14. The method of claim 13, furthercomprising constructing a look-up table for the function of the timeconstant and the results of the division of the first area by the secondarea.
 15. The method of claim 14, further comprising determining amagnitude of the exponential function using the first area, the secondarea, and the time constant.
 16. The method of claim 15, wherein thedetermining further comprises calculating the projected controltemperature based on the signal from the temperature sensor as measuredat the end of the second interval, the magnitude of the exponentialfunction, and the time constant of the exponential function.
 17. Themethod of claim 2, wherein the second interval of time is at least oneminute.
 18. The method of claim 2, wherein the time during which theworking fluid is caused to stop circulating, divided by the sum of thetime during which the working fluid is caused to stop circulating plusthe time during which the working fluid is circulating, is greater thanabout 90%.
 19. The method of claim 2, wherein the determining includes:assuming a range of time constants for an exponential; performing aleast squares fit between the collected data and the exponential foreach of the range of time constants to calculate an error value that isa function of the time constant; and minimizing the error value todetermine a unique value of the time constant.
 20. The method of claim19, further comprising using the unique value of the time constant todetermine the projected control temperature.
 21. The method of claim 19,further comprising determining the magnitude of the exponential.
 22. Themethod of claim 19, further comprising determining a first-order linearcomponent and adding the first-order linear component to the exponentialto determine the projected control temperature.
 23. The method claim 22,further comprising determining a higher-order components and adding thehigher-order components to the exponential to determine the projectedcontrol temperature.
 24. The method of claim 22, further comprisingadministering an anti-shivering agent to the patient.
 25. The method ofclaim 1, wherein the temperature sensor is selected from the groupconsisting of thermistors, thermocouples, and combinations thereof. 26.The method of claim 25, wherein the temperature sensor is twothermistors, and further comprising receiving a safety monitor signalfrom one of the two thermistors.
 27. The method of claim 26, furthercomprising causing the working fluid to stop circulating if a value ofcontrol temperature measured by the safety monitor signal falls outsidea predetermined range.
 28. The method of claim 27, wherein thepredetermined range is 31° C. to 37° C.
 29. The method of claim 1,wherein tile temperature sensor is disposed in a polymer tube.
 30. Themethod of claim 29, wherein the polymer is polyamide.
 31. The method ofclaim 1, wherein the temperature sensor is a thermistor.
 32. The methodof claim 1, wherein the working fluid has a temperature below thecurrent patient temperature, and wherein the predetermined period oftime is greater than about 30 minutes.
 33. The method of claim 1,wherein the working fluid has a temperature above the current patienttemperature, and wherein the predetermined period of time is greaterthan about 15 minutes.
 34. The method of claim 1, wherein thepredetermined period of time is directly proportional to the differencebetween the current patient temperature and the target patienttemperature.
 35. The method of claim 1, wherein the circulating includescirculating the working fluid at a maximum pump speed.
 36. The method ofclaim 1, wherein the circulating includes circulating the working fluidat a power of pump speed which is proportional to the difference betweenthe current patient temperature and the target patient temperature. 37.The method of claim 1, wherein the predetermined period of rime isdetermined by the initial patient temperature minus the sum of thetarget patient temperature and a constant, divided by the maximum rateof change of temperature, pertaining to a desired thermal therapy. 38.The method of claim 37, wherein the desired thermal therapy is inducinghypothermia.
 39. The method of claim 37, wherein the desired thermaltherapy is rewarming.
 40. The method of claim 1, wherein the temperaturesensor is encapsulated in a metal tube.
 41. A heat transfer catheter forinducing a therapeutic state of hypothermia in a patient, formaintaining the temperature of a patient, or for rewarming a patient,comprising: a catheter having a proximal end capable of being coupled toan input of a source of working fluid and a distal end coupled to a heattransfer element; a supply lumen disposed within the catheter, theproximal end of the supply lumen capable of being coupled to an outputof a source of working fluid and a distal end terminating at or withinthe heat transfer element; and a temperature sensor disposed on orwithin the heat transfer element, wherein the heat transfer elementincludes at least two heat transfer segments separated by a flexiblejoint, and wherein the heat transfer segments have helical ridges andgrooves.
 42. The catheter of claim 41, wherein the flexible jointincludes bellows.
 43. A heat transfer catheter for inducing atherapeutic stale of hypothermia in a patient, for maintaining thetemperature of a patient, or for rewarming a patient, comprising: acatheter having a proximal end capable of being coupled to an input of asource of working fluid and a distal end coupled to a heat transferelement; a supply lumen disposed within the catheter, the proximal endof the supply lumen capable of being coupled to an output of a source ofworking fluid and a distal end terminating at or within the heattransfer element; and a temperature sensor disposed on or within theheat transfer element, wherein the heat transfer element includes astraight supply lumen and a helical return lumen, the helical returnlumen encircling the straight supply lumen.
 44. The catheter of claim43, wherein the heat transfer element includes a straight supply lumenand multiple helical return lumens, the multiple helical return lumensencircling the straight supply lumen.